ACAN
aggrecan
ACAN; aggrecan; AGC1; SEDK; AGCAN; CSPG1; MSK16; CSPGCP; aggrecan core protein; large aggregating proteoglycan; cartilage-specific proteoglycan core protein; chondroitin sulfate proteoglycan core protein 1;
Ache
acetylcholinesterase (Yt blood group)
ACHE; acetylcholinesterase (Yt blood group); YT; ACEE; ARACHE; N-ACHE;
AGR2
anterior gradient 2 homolog (Xenopus laevis)
AGR2; anterior gradient 2 homolog (Xenopus laevis); anterior gradient protein 2 homolog; AG2; HAG 2; PDIA17; protein disulfide isomerase family A; member 17; XAG 2; AG-2; HPC8; anterior gradient homolog 2; secreted cement gland homolog; secreted cement gl;
AIF1
allograft inflammatory factor 1
AIF1; allograft inflammatory factor 1; IBA1; IRT1; AIF-1; IRT-1; protein G1; interferon gamma responsive transcript; ionized calcium-binding adapter molecule 1; allograft inflammatory factor-1 splice variant Hara-1;
BIN1
bridging integrator 1
BIN1; bridging integrator 1; AMPHL; myc box-dependent-interacting protein 1; AMPH2; amphiphysin II; SH3P9; amphiphysin-like protein; box dependant MYC interacting protein 1; box-dependent myc-interacting protein 1; MGC10367; DKFZp547F068;
BSG
basigin (Ok blood group)
BSG; basigin (Ok blood group); M6; OK; 5F7; TCSF; CD147; EMMPRIN; basigin; CD147 antigen; OK blood group antigen; collagenase stimulatory factor; leukocyte activation antigen M6; extracellular matrix metalloproteinase inducer; tumor cell-derived collagenase stimulatory factor;
CD44
CD44 molecule (Indian blood group)
CD44; CD44 molecule (Indian blood group); IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1; CDW44; CSPG8; HCELL; HUTCH-I; ECMR-III; CD44 antigen; epican; Hermes antigen; hyaluronate receptor; phagocytic glycoprotein 1; heparan sulfate proteoglycan; cell surface glycoprotein CD44; extracellular matrix receptor III; chondroitin sulfate proteoglycan 8; GP90 lymphocyte homing/adhesion receptor; hematopoietic cell E- and L-selectin ligand; homing function and Indian blood group system;
CD55
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); DAF, decay accelerating factor for complement (CD55, Cromer blood group system); complement decay-accelerating factor; CR; CROM; TC; CD55 antigen; DAF;
CHGA
chromogranin A (parathyroid secretory protein 1)
CHGA; chromogranin A (parathyroid secretory protein 1); chromogranin-A; SP-I; pituitary secretory protein I; parathyroid secretory protein 1; betagranin (N-terminal fragment of chromogranin A); CGA; CgA; Pancreastatin;
CHGB
chromogranin B (secretogranin 1)
CHGB; chromogranin B (secretogranin 1); secretogranin-1; Secretogranin I; CCB peptide; Cg B; CgB; Chromogranin-B; ChromograninB; GAWK peptide; SCG1; SCG1_HUMAN; Secretogranin 1; Secretogranin B; Secretogranin I precursor; SgI;
CIB1
calcium and integrin binding 1 (calmyrin)
CIB1; calcium and integrin binding 1 (calmyrin); CIB; CIBP; KIP1; PRKDCIP; SIP2-28; calcium and integrin-binding protein 1; DNA-PK interaction protein; DNA-PKcs-interacting protein; SNK-interacting protein 2-28; DNA-dependent protein kinase interacting protein;
CIB2
calcium and integrin binding family member 2
CIB2; calcium and integrin binding family member 2; calcium and integrin-binding family member 2; KIP2; KIP 2; 2810434I23Rik; kinase-interacting protein 2; DNA-dependent protein kinase catalytic subunit-interacting protein 2;
CRCP
CGRP receptor component
CRCP;CGRP receptor component;DNA-directed RNA polymerase III subunit RPC9;calcitonin gene related peptide receptor component protein;CGRP RCP;RCP;RCP9;RNA polymerase III subunit C9;CGRP-receptor component protein;calcitonin gene-related peptide-receptor component protein;CGRPRCP;CGRP-RCP;MGC111194;
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
CSF2; colony stimulating factor 2 (granulocyte-macrophage); GMCSF; granulocyte-macrophage colony-stimulating factor; CSF; molgramostin; sargramostim; granulocyte-macrophage colony-stimulating-factor; GM-CSF;
CSF2RA
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
CSF2RA; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); granulocyte-macrophage colony-stimulating factor receptor subunit alpha; GMR-alpha; GM-CSFRalpha; GMCSFR-alpha; GM-CSF-R-alpha; colony stimulating factor 2 receptor alpha chain; CD116; Csfgmra; GM-CSFR; GM-CSF-Ra;
CSF2RB
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
CSF2RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); IL3RB; cytokine receptor common subunit beta; CD131; IL5RB; GM-CSF/IL-3/IL-5 receptor common beta-chain; GM-CSF/IL-3/IL-5 receptor common beta subunit; colony-stimu;
CSF3
Colony Stimulating Factor 3 (Granulocyte)
CSF3; GCSF; CSF3OS; C17orf33; MGC45931; granulocyte colony-stimulating factor; filgrastim; lenograstim; pluripoietin; OTTHUMP00000164325; OTTHUMP00000164326; OTTHUMP00000164327; OTTHUMP00000164328;
CSF3R
CSF3R colony stimulating factor 3 receptor (granulocyte)
CSF3R; colony stimulating factor 3 receptor (granulocyte); CD114; granulocyte colony-stimulating factor receptor; GCSFR; G-CSF-R; CD114 antigen; G-CSF receptor;
CTGF
connective tissue growth factor
CTGF; connective tissue growth factor; CCN2; NOV2; HCS24; IGFBP8; IBP-8; IGFBP-8; CCN family member 2; IGF-binding protein 8; hypertrophic chondrocyte-specific protein 24; insulin-like growth factor-binding protein 8;
EGF
epidermal growth factor
Beta urogastrone; EGF; EGF-HUMAN; Epidermal Growth Factor; HOMG4; OTTHUMP00000219721; OTTHUMP00000219722; Pro epidermal growth factor; URG; Urogastrone;
EGFR
epidermal growth factor receptor
EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) , ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; ERBB; HER1; mENA; PIG61;
EGR1
early growth response 1
EGR1; early growth response 1; TIS8; AT225; G0S30; NGFI-A; ZNF225; KROX-24; ZIF-268; early growth response protein 1; EGR-1; zinc finger protein 225; transcription factor ETR103; transcription factor Zif268; zinc finger protein Krox-24; nerve growth factor-induced protein A;
EGR3
early growth response 3
EGR3; early growth response 3; EGR-3; PILOT; early growth response protein 3; zinc finger protein pilot;
EGR4
early growth response 4
EGR4; early growth response 4; early growth response protein 4; NGFI C; PAT133; AT133; Nerve growth factor induced clone C; NGFIC; EGR-4; NGFI-C;
ERCC1
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)
ERCC1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence); DNA excision repair protein ERCC-1; RAD10; UV20; COFS4;
ERCC3
excision repair cross-complementation group 3
ERCC3; excision repair cross-complementation group 3; XPB; BTF2; GTF2H; RAD25; TFIIH; TFIIH basal transcription factor complex helicase XPB subunit; BTF2 p89; TFIIH p89; TFIIH 89 kDa subunit; DNA excision repair protein ERCC-3; DNA repair protein complementing XP-B cells; basic transcription factor 2 89 kDa subunit; xeroderma pigmentosum, complementation group B; xeroderma pigmentosum group B-complementing protein; TFIIH basal transcription factor complex 89 kDa subunit; excision repair cross-complementing rodent repair deficiency, complementation group 3;
ERCC6
excision repair cross-complementing rodent repair deficiency, complementation group 6
ERCC6; excision repair cross-complementing rodent repair deficiency, complementation group 6; CSB; CKN2; COFS; ARMD5; COFS1; RAD26; DNA excision repair protein ERCC-6; Rad26 homolog; Cockayne syndrome B protein; ATP-dependent helicase ERCC6; cockayne syndrome protein CSB; Cockayne syndrome group B protein; OTTHUMP00000019581; EC 3.6.4.-; EC 3.6.1;
FGF1
fibroblast growth factor 1 (acidic)
FGF1; Fibroblast Growth Factor-acidic; FGF-acidic; Basic fibroblast growth factor; BFGF; FGF 2; FGF B; FGF2; FGF2 basic; FGF2_HUMAN; FGFB; Fibroblast growth factor 2 (basic); HBGF 2; HBGF-2; HBGF2; HBGH 2; HBGH2; Heparin binding growth factor 2 precursor; Heparin-binding growth factor 2; Prostatropin;
FGF10
fibroblast growth factor 10
FGF10; fibroblast growth factor 10; FGF-10; keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria;
FGF12
fibroblast growth factor 12
FGF12; fibroblast growth factor 12; FGF12B; FHF1; fibroblast growth factor 12B; fibroblast growth factor FGF 12b; fibroblast growth factor homologous factor 1; myocyte activating factor; FHF-1; FGF-12; myocyte-activating factor; fibroblast growth factor F;
FGF17
fibroblast growth factor 17
FGF17; fibroblast growth factor 17; FGF 13; FGF13; FGF-17; OTTHUMP00000122553; OTTHUMP00000224730; FGF-13;
FGF2
Fibroblast Growth Factor 2 (basic)
FGF2; fibroblast growth factor 2 (basic); BFGF; FGFB; HBGF-2; heparin-binding growth factor 2; prostatropin; OTTHUMP00000037513; basic fibroblast growth factor bFGF; Fgf-2;
FGF23
fibroblast growth factor 23
FGF23; fibroblast growth factor 23; ADHR; FGFN; HYPF; HPDR2; PHPTC; phosphatonin; tumor-derived hypophosphatemia inducing factor;
FGF4
fibroblast growth factor 4
FGF4; fibroblast growth factor 4; heparin secretory transforming protein 1 , HSTF1; HBGF 4; HST; HST 1; human stomach cancer; transforming factor from FGF related oncogene; K FGF; kaposi sarcoma oncogene; KFGF; transforming protein KS3; FGF-4; HSTF-1; onc;
FGF5
fibroblast growth factor 5
FGF5; fibroblast growth factor 5; heparin-binding growth factor 5; HBGF-5; Smag-82;
FGF6
fibroblast growth factor 6
FGF6; fibroblast growth factor 6; FGF-6; HST-2; HSTF-2; OTTHUMP00000238378; heparin-binding growth factor 6; heparin secretory-transforming protein 2; HST2; HBGF-6;
FGF7
Fibroblast growth factor 7
FGF7; fibroblast growth factor 7; KGF; HBGF-7; keratinocyte growth factor; OTTHUMP00000162252; heparin-binding growth factor 7; HBGF 7; HBGF7; FGF 7; FGF-7; Heparin binding growth factor 7;
FGF8
fibroblast growth factor 8 (androgen-induced)
FGF8; fibroblast growth factor 8 (androgen-induced); fibroblast growth factor 8; AIGF; androgen-induced growth factor; heparin-binding growth factor 8; KAL6; FGF-8; HBGF-8; MGC149376;
FGF9
Fibroblast growth factor 9 (glia-activating factor)
FGF9; fibroblast growth factor 9 (glia-activating factor); GAF; SYNS3; HBFG-9; Glia-activating factor; Fibroblast growth factor 9; FGF-9; Heparin-binding growth factor 9; OTTHUMP00000018804; heparin-binding growth factor;
FGFR1
fibroblast growth factor receptor 1
FLG; FGFR1; fibroblast growth factor receptor 1; CEK; OGD; FLT2; KAL2; BFGFR; CD331; FGFBR; FLT-2; HBGFR; N-SAM; FGFR-1; FLJ99988; bFGF-R-1; OTTHUMP00000190874; OTTHUMP00000190875; OTTHUMP00000190876; OTTHUMP00000190877; OTTHUMP00000190879; OTTHUMP00000190880; OTTHUMP00000190881; OTTHUMP00000190885; proto-oncogene c-Fgr; FMS-like tyrosine kinase 2; hydroxyaryl-protein kinase; fms-related tyrosine kinase 2; heparin-binding growth factor receptor; H2; H3; H4; H5; Basic fibroblast growth factor receptor 1; N sam tyrosine kinase; Protein tyrosine kinase; Tyrosylprotein kinase; Hydroxyaryl protein kinase; Heparin binding growth factor receptor;
FGFR2
fibroblast growth factor receptor 2
FGFR2; BEK; JWS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; Crouzon syndrome; Pfeiffer syndrome; fibroblast growth factor receptor 2; OTTHUMP00000020623; Keratinocyte growth factor receptor; OTTHUMP00000020624; OTTHUMP00000020625; OTTHUMP00000020626; OTTHUMP00000020627; OTTHUMP00000020628; OTTHUMP00000020629; OTTHUMP00000020630; OTTHUMP00000020631; bacteria-expressed kinase; OTTHUMP00000020632; FGFR-2; BEK fibroblast growth factor receptor; FGF receptor; EC 2.7.10.1; hydroxyaryl-protein kinase; protein tyrosine kinase, receptor like 14; soluble FGFR4 variant 4; craniofacial dysostosis 1; Jackson-Weiss syndrome; KSAM; CD332 antigen; FLJ98662; EC 2.7.10; OTTHUMP00000020621;
Fgfr3
fibroblast growth factor receptor 3
FGFR3; fibroblast growth factor receptor 3; ACH; CEK2; JTK4; CD333; HSFGFR3EX; FGFR-3; tyrosine kinase JTK4; hydroxyaryl-protein kinase; fibroblast growth factor receptor 3 variant 4;
FGFR4
fibroblast growth factor receptor 4
FGFR4; fibroblast growth factor receptor 4; TKF; JTK2; CD334; FGFR-4; tyrosylprotein kinase; protein-tyrosine kinase; hydroxyaryl-protein kinase; tyrosine kinase related to fibroblast growth factor receptor;
FGFRL1
fibroblast growth factor receptor-like 1
FGFRL1; fibroblast growth factor receptor-like 1; FGF homologous factor receptor; FGF receptor like protein 1; FGFR 5; FGFR like protein; FGFR5; FHFR; Fibroblast growth factor receptor 5; Fibroblast growth factor receptor like 1; FGFR-5; FGFR-like protein; FGF receptor-like protein 1;
FIBP
fibroblast growth factor (acidic) intracellular binding protein
FIBP;fibroblast growth factor (acidic) intracellular binding protein;acidic fibroblast growth factor intracellular-binding protein;FGFIBP;aFGF intracellular-binding protein;FGF-1 intracellular-binding protein;FIBP-1;
FIGF
C-fos induced growth factor (vascular endothelial growth factor D)
VEGF-D; VEGFD; vascular endothelial growth factor D;
FRS3
Frs3 fibroblast growth factor receptor substrate 3
FRS3; fibroblast growth factor receptor substrate 3; FRS2-beta; FGFR substrate 3; suc1-associated neurotrophic factor target 2 (FGFR signalling adaptor); Snt2; AI449674; Frs2beta; 4930417B13Rik; MGC25496;
FYN
FYN oncogene related to SRC, FGR, YES
FYN; FYN oncogene related to SRC, FGR, YES; tyrosine-protein kinase Fyn; MGC45350; SLK; SYN; src-like kinase; proto-oncogene Syn; c-syn protooncogene; proto-oncogene c-Fyn; src/yes-related novel; tyrosine kinase p59fyn(T); OKT3-induced calcium influx regu;
GAB1
GAB1 GRB2-associated binding protein 1
GAB1; GRB2-associated binding protein 1; GRB2-associated-binding protein 1; GRB2-associated binder 1; growth factor receptor bound protein 2-associated protein 1;
GADD45A
growth arrest and DNA-damage-inducible, alpha
GADD45A; growth arrest and DNA-damage-inducible, alpha; DDIT1; growth arrest and DNA damage-inducible protein GADD45 alpha; GADD45; DDIT-1; DNA damage-inducible transcript-1; DNA-damage-inducible transcript 1; DNA damage-inducible transcript 1 protein; gr;
GADD45B
growth arrest and DNA-damage-inducible, beta
GADD45B; growth arrest and DNA-damage-inducible, beta; MYD118; growth arrest and DNA damage-inducible protein GADD45 beta; DKFZP566B133; GADD45BETA; growth arrest and DNA damage inducible beta; myeloid differentiation primary response; negative growth reg;
GADD45G
growth arrest and DNA-damage-inducible, gamma
GADD45G; growth arrest and DNA-damage-inducible, gamma; growth arrest and DNA damage-inducible protein GADD45 gamma; CR6; DDIT2; gadd related protein; 17 kD; GADD45gamma; growth arrest and DNA damage inducible gamma; GRP17; DDIT-2; GADD45-gamma; gadd-rela;
Gas6
growth arrest-specific 6
GAS6; growth arrest-specific 6; AXSF; AXLLG; growth arrest-specific protein 6; AXL stimulatory factor; AXL receptor tyrosine kinase ligand;
GAS7
growth arrest-specific 7
GAS7; growth arrest-specific 7; growth arrest-specific protein 7; KIAA0394; MGC1348; Growth arrest specific 7; GAS 7; GAS-7; GAS7_HUMAN; MLL/GAS7; MLL/GAS7 fusion protein;
GCA
grancalcin, EF-hand calcium binding protein
GCA; grancalcin, EF-hand calcium binding protein; grancalcin, EF hand calcium binding protein; grancalcin; GCL; OTTHUMP00000162937; OTTHUMP00000204639; grancalcin, penta-EF-hand protein; grancalcin, EF-hand calcium-binding protein;
GDF10
growth differentiation factor 10
GDF10; growth differentiation factor 10; bone morphogenetic protein 3B; BMP 3b; BIP; GDF-10; bone-inducing protein; BMP3B; BMP-3b;
GDF11
growth differentiation factor 11
GDF11; growth differentiation factor 11; growth/differentiation factor 11; BMP 11; GDF-11; bone morphogenetic protein 11; BMP11; BMP-11;
GDF15
growth differentiation factor 15
GDF15; growth differentiation factor 15; PDF; MIC1; PLAB; MIC-1; NAG-1; PTGFB; GDF-15; growth/differentiation factor 15; NRG-1; PTGF-beta; placental TGF-beta; NSAID-activated gene 1 protein; NSAID-regulated gene 1 protein; prostate differentiation factor; macrophage inhibitory cytokine 1; placental bone morphogenetic protein; NSAID (nonsteroidal anti-inflammatory drug)-activated protein 1;
GDF2
growth differentiation factor 2
BMP-9; BMP9; GDF2; growth differentiation factor 2; GDF-2; bone morphogenetic protein 9; growth/differentiation factor 2; Human BMP9 ELISA KIT; Human; BMP9 ELISA KIT; ELISA KIT; BMP9 ELISA; KIT; ELISA;
GDF3
growth differentiation factor 3
GDF3; growth differentiation factor 3; KFS3; MCOP7; MCOPCB6; growth/differentiation factor 3; GDF-3;
GDF5
growth differentiation factor 5
GDF5; growth differentiation factor 5; growth/differentiation factor 5; BMP14; cartilage derived morphogenetic protein 1; CDMP1; GDF-5; CDMP-1; radotermin; cartilage-derived morphogenetic protein-1; OS5; LAP4; SYNS2;
GDF6
growth differentiation factor 6
GDF6; growth differentiation factor 6; growth/differentiation factor 6; BMP13; GDF-6; Klippel-Feil syndrome; Klip-Feil malformation; Klippel-Feil malformation; growth/differentiation factor 16; KFM; KFS; KFS1; KFSL; SGM1; CDMP2; MCOP4; SCDO4; MCOPCB6; MGC;
GDF9
growth differentiation factor 9
GDF9; growth differentiation factor 9; growth/differentiation factor 9; GDF-9;
GH1
growth hormone 1
gH; GH-N; GH1; GHN; Growth hormone 1; Growth hormone; Growth hormone, normal; Growth hormone, pituitary; HG1; hGH-N; IGHD1B; Pituitary growth hormone; RNGHGP; SOMA_HUMAN; Somatotropin;
GH2
growth hormone 2
GH2; growth hormone 2; growth hormone variant; GH V; GHL; GHV; hGH V; placenta specific growth hormone; placental specific growth hormone; GH 2; hGHV; placenta-specific growth hormone; placental-specific growth hormone; GH-V; hGH-V;
GHR
growth hormone receptor
GHR; growth hormone receptor; GHBP; GH receptor; serum binding protein; somatotropin receptor; growth hormone binding protein;
GHRH
Ghrh growth hormone releasing hormone
GHRH; growth hormone releasing hormone; somatoliberin; GRF; growth hormone-releasing factor; growth hormone-releasing hormone; GHRF;
GRAMD3
GRAM domain containing 3
GRAMD3; GRAM domain containing 3; GRAM domain-containing protein 3; FLJ21313; HCV NS3 transactivated protein 2; NS3TP2; HCV NS3-transactivated protein 2; hepatitis C virus nonstructural protein 3-transactivating protein 2;
GRAP2
GRB2-related adaptor protein 2
GRAP2; GRB2-related adaptor protein 2; GRB2-related adapter protein 2; GADS; GRBLG; GrbX; Grf40; Mona; grf-40; GRB-2-like protein; adapter protein GRID; grf40 adapter protein; SH3-SH2-SH3 adapter Mona; SH3-SH2-SH3 adaptor molecule; growth factor receptor-binding protein; GRB2-related protein with insert domain; hematopoietic cell-associated adapter protein GrpL; hematopoietic cell-associated adaptor protein GRPL; growth factor receptor-bound protein 2-related adaptor protein 2; P38; GRID; GRPL; GRB2L; GRAP-2;
GRB10
growth factor receptor-bound protein 10
GRB10; growth factor receptor-bound protein 10; GRB10 adapter protein; GRB10 adaptor protein; maternally expressed gene 1; insulin receptor-binding protein Grb-IR; RSS; IRBP; MEG1; GRB-IR; Grb-10; KIAA0207;
GRB2
growth factor receptor-bound protein 2
GRB2; growth factor receptor-bound protein 2; ASH; Grb3-3; MST084; NCKAP2; MSTP084; EGFRBP-GRB2; HT027; protein Ash; SH2/SH3 adapter GRB2; abundant SRC homology; growth factor receptor-bound protein 3; epidermal growth factor receptor-binding protein GRB2;
GREM2
gremlin 2
GREM2; gremlin 2; gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis); gremlin-2; CKTSF1B2; DAND3; FLJ21195; Prdc; protein related to DAN and cerberus; Cysteine knot superfamily 1 BMP antagonist 2; DAN domain family member 3; DAND 3; GREM 2; Gremlin 2 cysteine knot superfamily homolog; Gremlin2; cysteine knot superfamily 1, BMP antagonist 2; gremlin 2, cysteine knot superfamily, homolog;
GRN
granulin
GRN; granulin; GEP; GP88; PEPI; PGRN; PCDGF; progranulin; Acrogranin; Granulin-1; Granulin G; Granulin-2; Granulin F; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7; Granulin A; Granulin C; Granulin D; Granulin E; granulin-epithelin; proepithelin; PC cell-derived growth factor;
GroEL
chaperonin GroEL
groEL; chaperonin GroEL; 60 kDa chaperonin; groEL protein; groL; mopA; Protein Cpn60; 60 kDa chaperone family; promotes refolding of misfolded polypeptides especially under stressful conditions; forms two stacked rings of heptamers to form a barrel-shaped 14mer; ends can be capped by GroES; misfolded proteins enter the barrel where they ar;
GRPEL1
GrpE-like 1, mitochondrial (E. coli)
GRPEL1; GrpE-like 1, mitochondrial (E. coli); grpE protein homolog 1, mitochondrial; FLJ25609; HMGE; GREPEL 1; GREPEL1; GrpE like 1; GrpE like 1 mitochondrial; GrpE like protein cochaperone; GrpE protein homolog 1 mitochondrial; GRPE1_HUMAN; GRPEL 1; Mt GrpE#1; Mt-GrpE#1; GrpE-like protein cochaperone;
GZMB
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1); HLP; CCPI; CGL1; CSPB; SECT; CGL-1; CSP-B; CTLA1; CTSGL1; granzyme B; C11; CTLA-1; fragmentin 2; fragmentin-2; cathepsin G-like 1; human lymphocyte protein; T-cell serine protease 1-3E; cytotoxic serine protease B; cytotoxic T-lymphocyte proteinase 2;
GZMH
granzyme H (cathepsin G-like 2, protein h-CCPX)
GZMH; granzyme H (cathepsin G-like 2, protein h-CCPX); CTSGL2; granzyme H; CCP X; CGL 2; CSP C; CTLA1; Cathepsin G like 2; CGL2; Cytotoxic serine protease C; Cytotoxic T lymphocyte associated serine esterase 1; Cytotoxic T lymphocyte proteinase; EC 3.4.21.-; Protein h CCPX; OTTHUMP00000178753; OTTHUMP00000245745; cathepsin G-like 2; cytotoxin serine protease-C; cytotoxic T-lymphocyte proteinase; cytotoxic T-lymphocyte-associated serine esterase 1; CCP-X; CGL-2; CSP-C;
GZMK
granzyme K (granzyme 3
GZMK; granzyme K (granzyme 3; tryptase II); TRYP2; granzyme K; NK-Tryp-2; granzyme 3; granzyme-3; tryptase II; fragmentin-3; NK-tryptase-2; granzyme K (serine protease, granzyme 3; tryptase II);
HBEGF
heparin-binding EGF-like growth factor
HBEGF; heparin-binding EGF-like growth factor; diphtheria toxin receptor (heparin binding epidermal growth factor like growth factor) , DTR, DTS, HEGFL; proheparin-binding EGF-like growth factor; Diphtheria toxin receptor (heparin binding EGF like growth factor); heparin binding epidermal growth factor; Diphtheria toxin receptor; DT R; DT-R; DTR; DTS; DTSF; HB-EGF; HBEGF_HUMAN; HEGFL; Heparin binding EGF like growth factor; Heparin binding epidermal growth factor like growth factor; OTTHUMP00000159876; heparin-binding epidermal growth factor; diphtheria toxin receptor (heparin-binding EGF-like growth factor); diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor);
HDGF
hepatoma-derived growth factor
HDGF; hepatoma-derived growth factor; hepatoma derived growth factor (high mobility group protein 1 like); high mobility group protein 1 like; HMG1L2; HMG-1L2; high mobility group protein 1-like 2; FLJ96580; DKFZp686J1764;
HGF
hepatocyte growth factor (hepapoietin A; scatter factor)
SF; HGFB; HPTA; F-TCF; DFNB39;Fibroblast derived tumor cytotoxic factor; Hepatocyte growth factor; Hepatocyte growth factor beta chain; Hepatocyte growth factor precursor; Hepatopoeitin-A; Hepatopoietin A; Hgf; Lung fibroblast derived mitogen; OTTHUMP00000161349; OTTHUMP00000206710; OTTHUMP00000206711; OTTHUMP00000206712; OTTHUMP00000206713; OTTHUMP00000206730; Scatter factor; Rilotumumab; 872514-65-3; Flanvotumab; 1188277-05-5;
HMGB1
high mobility group box 1
HMGB1; high mobility group box 1; high mobility group (nonhistone chromosomal) protein 1 , high mobility group box 1 , HMG1; high mobility group protein B1; Amphoterin; DKFZp686A04236; high mobility group protein 1; HMG3; SBP 1; Sulfoglucuronyl carbohydrate binding protein; HMG-1; high-mobility group box 1; high-mobility group (nonhistone chromosomal) protein 1; HMG1; SBP-1;
HMGN1
high mobility group nucleosome binding domain 1
HMGN1; high mobility group nucleosome binding domain 1; high mobility group (nonhistone chromosomal) protein 14 , high mobility group nucleosome binding domain 1 , HMG14; non-histone chromosomal protein HMG-14; FLJ27265; FLJ31471; high mobility group nuc;
HSP90B1
heat shock protein 90kDa beta (Grp94), member 1
HSP90B1; heat shock protein 90kDa beta (Grp94), member 1; TRA1, tumor rejection antigen (gp96) 1; endoplasmin; GP96; GRP94; GRP-94; gp96 homolog; tumor rejection antigen 1; 94 kDa glucose-regulated protein; Tumor rejection antigen-1 (gp96); tumor rejection antigen (gp96) 1; glucose regulated protein, 94 kDa; endothelial cell (HBMEC) glycoprotein; heat shock protein 90 kDa beta member 1; ECGP; TRA1;
IBSP
integrin-binding sialoprotein
integrin-binding sialoprotein; Cell-binding sialoprotein; BSP; BNSP; BSP-II; BSP II; SP-II; bone sialoprotein 2; Bone sialoprotein II; OTTHUMP00000161175; IBSP;
Ide
insulin-degrading enzyme
IDE; insulin-degrading enzyme; INSULYSIN; insulinase; insulin protease; Abeta-degrading protease;
IFNGR1
IFNGR1 interferon gamma receptor 1
IFNGR1; interferon gamma receptor 1; IFNGR; CD119; CDw119; AVP, type 2; IFN-gamma-R1; CD119 antigen; IFN-gamma receptor 1; antiviral protein, type 2; immune interferon receptor 1; interferon-gamma receptor alpha chain; FLJ45734;
IGF1
Insulin-like growth factor 1
ProIGF-I; Insulin-like Growth Factor-I Precursor; IGF-IEB; IGF1; IGFI; Insulin-like Growth Factor-I; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1; IGF1A; insulin-like growth factor I; Mechano growth factor; insulin-like growth factor IA; IGF-I; insulin-like growth factor IB; MGF; somatomedin-C; IGF-IA; IBP1; IGF-IB; Somatomedin-C; IGFI; Teprotumumab; 89957-37-9; Ganitumab; 905703-97-1;
IGF1R
insulin-like growth factor 1 receptor
IGF1R; insulin-like growth factor 1 receptor; IGFR; CD221; IGFIR; JTK13; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor;
IGF2
Insulin-like Growth Factor-II
IGF2; IGF-II; PP9974; C11orf43; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734; insulin-like growth factor 2 (somatomedin A); C11orf43, chromosome 11 open reading frame 43; insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; PP9974;
IGF2R
Insulin-like Growth Factor 2 Receptor
cation-independent mannose-6-phosphate receptor; M6PR; CI-MPR; MPR 300; M6P/IGF2R; IGF-II receptor; M6P/IGF2 receptor; OTTHUMP00000017536; CI Man-6-P receptor; 300 kDa mannose 6-phosphate receptor; MPR1; insulin-like growth factor II receptor; cation-independent mannose-6 phosphate receptor; CD222 antigen; MPRI; CD222; CIMPR; M6P-R; IGF2R; insulin-like growth factor 2 receptor;
IGFBP1
Insulin-like Growth Factor Binding Protein 1
AFBP; IBP1; PP12; IGF-BP25; hIGFBP-1; IGFBP1; insulin-like growth factor-binding protein 1; IBP-1; IGFBP-1; OTTHUMP00000159561; OTTHUMP00000207990; OTTHUMP00000214348; binding protein-25; binding protein-26; binding protein-28; placental protein 12; IGF-binding protein 1; amniotic fluid binding protein; growth hormone independent-binding protein; alpha-pregnancy-associated endometrial globulin;
IGFBP2
insulin-like growth factor binding protein 2, 36kDa
IGFBP2; insulin-like growth factor binding protein 2, 36kDa; IBP2; IGF-BP53; insulin-like growth factor-binding protein 2; IBP-2; IGFBP-2; IGF-binding protein 2;
IGFBP3
IGFBP3 insulin-like growth factor binding protein 3
IGFBP3; insulin-like growth factor binding protein 3; insulin-like growth factor-binding protein 3; acid stable subunit of the 140 K IGF complex; binding protein 29; binding protein 53; BP 53; growth hormone dependent binding protein; IBP3; IGF binding protein 3; IBP-3; IGFBP-3; IGF-binding protein 3; growth hormone-dependent binding protein; BP-53;
IGFBP4
insulin-like growth factor binding protein 4
IGFBP4; insulin-like growth factor binding protein 4; BP-4; IBP4; IGFBP-4; HT29-IGFBP; insulin-like growth factor-binding protein 4; IBP-4; IGF-binding protein 4; Insulin-like growth factor-binding protein 4;
IGFBP5
insulin-like growth factor binding protein 5
IGFBP5; insulin-like growth factor binding protein 5; IBP5; insulin-like growth factor-binding protein 5; IBP-5; IGFBP-5; IGF-binding protein 5; Insulin-like growth factor-binding protein 5;
IGFBP6
IGFBP6 insulin-like growth factor binding protein 6
IGFBP6; insulin-like growth factor binding protein 6; insulin-like growth factor-binding protein 6; IBP-6; IGFBP-6; IGF binding protein 6; IGF-binding protein 6; IBP6;
IGFBP7
insulin-like growth factor binding protein 7
IGFBP7; insulin-like growth factor binding protein 7; AGM; PSF; TAF; FSTL2; IBP-7; MAC25; IGFBP-7; RAMSVPS; IGFBP-7v; IGFBPRP1; insulin-like growth factor-binding protein 7; IGFBP-rP1; angiomodulin; IGF-binding protein 7; PGI2-stimulating factor; tumor-derived adhesion factor; prostacyclin-stimulating factor;
ILK
integrin-linked kinase
ILK; integrin-linked kinase; integrin-linked protein kinase; ILK-1; p59ILK; integrin-linked kinase-2; 59 kDa serine/threonine-protein kinase; P59; ILK-2; DKFZp686F1765;
ING1
inhibitor of growth family, member 1
ING1; inhibitor of growth family, member 1; inhibitor of growth protein 1; growth inhibitor ING1; growth inhibitory protein ING1; inhibitor of growth 1; p24ING1c; p33; p33ING1; p33ING1b; p47; p47ING1a; tumor suppressor ING1;
ITGA4
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); IA4; CD49D;
Itgal
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1
ITGAL; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); CD11A; LFA-1; LFA1A; integrin alpha-L; LFA-1A; LFA-1 alpha; integrin gene promoter; CD11 antigen-like family member A; lymphocyte function-associated antigen 1; leukocyte adhesion glycoprotein LFA-1 alpha chain; leukocyte function-associated molecule 1 alpha chain; antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide;
ITGAM
integrin, alpha M (complement component 3 receptor 3 subunit)
ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit); CR3A; MO1A; CD11B; MAC-1; MAC1A; SLEB6; integrin alpha-M; CR-3 alpha chain; antigen CD11b (p170); leukocyte adhesion receptor MO1; CD11 antigen-like family member B; macrophage antigen alpha polypeptide; cell surface glycoprotein MAC-1 subunit alpha; neutrophil adherence receptor alpha-M subunit;
LOC100136741
insulin-like growth factor I
LOC100136741; insulin-like growth factor I; igf1; IGF-I; somatomedin;
MIF
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
MIF; macrophage migration inhibitory factor (glycosylation-inhibiting factor); GIF; GLIF; MMIF; Macrophage migration inhibitory factor; EC=5.3.2.1; Glycosylation-inhibiting factor; L-dopachrome isomerase; L-dopachrome tautomerase; EC=5.3.3.12; Phenylpyruvate tautomerase; OTTHUMP00000198465;
MST1
macrophage stimulating 1 (hepatocyte growth factor-like)
MST1; macrophage stimulating 1 (hepatocyte growth factor-like); D3F15S2, DNF15S2, HGFL; hepatocyte growth factor-like protein; hepatocyte growth factor like protein homolog; MSP; NF15S2; macrophage-stimulating protein; hepatocyte growth factor-like protei;
Ngf
nerve growth factor (beta polypeptide)
NGF; nerve growth factor (beta polypeptide); NGFB; HSAN5; Beta-NGF; beta-nerve growth factor; nerve growth factor, beta subunit;
NGFR
nerve growth factor receptor
NGFR; nerve growth factor receptor; p75; LNGFR; p75NTR; RNNGFRR; Tnfrsf16; tumor necrosis factor receptor superfamily member 16; p75 ICD; gp80-LNGFR; NGF receptor; nerve growth factor receptor, fast; low affinity nerve growth factor receptor; low affinity neurotrophin receptor p75NTR; low-affinity nerve growth factor receptor; nerve growth factor receptor (TNFR superfamily, member 16);
NGRN
neugrin, neurite outgrowth associated
NGRN; neugrin, neurite outgrowth associated; neugrin; DSC92; FI58Gm; Mesenchymal stem cell protein DSC92; Neugrin neurite outgrowth associated; Neurite outgrowth associated protein; Neurite outgrowth-associated protein; NGRN_HUMAN; Spinal cord-derived protein FI58G; OTTHUMP00000194683;
NR1H2
nuclear receptor subfamily 1, group H, member 2
NR1H2; nuclear receptor subfamily 1, group H, member 2; NER; UNR; LXRB; LXR-b; NER-I; RIP15; oxysterols receptor LXR-beta; LX receptor beta; nuclear receptor NER; liver X nuclear receptor beta; nuclear orphan receptor LXR-beta; steroid hormone-nuclear receptor NER; ubiquitously-expressed nuclear receptor;
NR1H3
NR1H3 nuclear receptor subfamily 1, group H, member 3
NR1H3; nuclear receptor subfamily 1, group H, member 3; oxysterols receptor LXR-alpha; liver X receptor alpha; LXR a; RLD 1; liver X nuclear receptor alpha variant 1; LXRA; LXR-a; RLD-1;
NR1H4
nuclear receptor subfamily 1, group H, member 4
NR1H4; nuclear receptor subfamily 1, group H, member 4; BAR; FXR; HRR1; HRR-1; RIP14; bile acid receptor; farnesol receptor HRR-1; RXR-interacting protein 14; farnesoid X nuclear receptor; farnesoid X-activated receptor; retinoid X receptor-interacting protein 14;
NR1I2
nuclear receptor subfamily 1, group I, member 2
NR1I2; nuclear receptor subfamily 1, group I, member 2; nuclear receptor subfamily 1 group I member 2; BXR; ONR1; PAR2; PXR; SXR; pregnane X receptor; orphan nuclear receptor PXR; orphan nuclear receptor PAR1; steroid and xenobiotic receptor; pregnane X n;
NR1I3
NR1I3 nuclear receptor subfamily 1, group I, member 3
NR1I3; nuclear receptor subfamily 1, group I, member 3; nuclear receptor subfamily 1 group I member 3; CAR; CAR1; constitutive androstane receptor; MB67; constitutive active receptor; constitutive active response; orphan nuclear receptor MB67; orphan nuclear hormone receptor; constitutive activator of retinoid response; constitutive androstane nuclear receptor variant 2; constitutive androstane nuclear receptor variant 3; constitutive androstane nuclear receptor variant 4; constitutive androstane nuclear receptor variant 5; MGC97144; MGC97209; MGC150433;
NR3C1
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
NR3C1; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); GR; GCR; GRL; GCCR; glucocorticoid receptor; glucocorticoid nuclear receptor variant 1;
NR5A2
NR5A2 nuclear receptor subfamily 5, group A, member 2
NR5A2; nuclear receptor subfamily 5, group A, member 2; FTF; nuclear receptor subfamily 5 group A member 2; B1F2; FTZ F1; FTZ F1beta; hB1F; hB1F 2; liver receptor homolog 1; LRH 1; nuclear receptor NR5A2; liver receptor homolog-1; CYP7A promoter-binding factor; hepatocytic transcription factor; alpha-1-fetoprotein transcription factor; liver nuclear receptor homolog-1 variant 2; fetoprotein-alpha 1 (AFP) transcription factor; b1-binding factor, hepatocyte transcription factor which activates enhancer II of hepatitis B virus; B1F; CPF; LRH1; LRH-1; FTZ-F1; hB1F-2; FTZ-F1beta;
NR1D2
nuclear receptor subfamily 1, group D, member 2
NR1D2; nuclear receptor subfamily 1, group D, member 2; nuclear receptor subfamily 1 group D member 2; BD73; EAR 1r; Hs.37288; HZF2; RVR; EAR-1R; NR1D2_HUMAN; Orphan nuclear hormone receptor BD73; Rev erb beta; Rev-erb-beta; REVB; REVERBB; V-erbA-related protein 1-related; OTTHUMP00000208397; rev-erba-alpha-related receptor; nuclear receptor Rev-ErbA beta variant 1; nuclear receptor Rev-ErbA beta var;
OSGIN1
oxidative stress induced growth inhibitor 1
OSGIN1; oxidative stress induced growth inhibitor 1; oxidative stress-induced growth inhibitor 1; BDGI; bone marrow stromal cell derived growth inhibitor; OKL38; pregnancy induced growth inhibitor; 1700012B18Rik; huOKL38; OKL 38; OSGIN 1; OTTHUMP00000174992; OTTHUMP00000174993; Ovary kidney and liver protein 38; Pregnancy induced growth inhibitor OKL38; ovary, kidney and liver protein 38; pregnancy-induced growth inhibitor OKL38; bone marrow stromal cell-derived growth inhibitor;
PDCD1
Pdcd1 programmed cell death 1
PDCD1; programmed cell death 1; programmed cell death protein 1; mPD-1; protein PD-1; PD-1; Pdc1; Ly101;
PDCD1LG2
PDCD1LG2 programmed cell death 1 ligand 2
PDCD1LG2; programmed cell death 1 ligand 2; B7 dendritic cell molecule; B7 DC; bA574F11.2; Btdc; CD273; PD L2; PDL2; B7-DC; PD-1 ligand 2; PD-1-ligand 2; PDCD1 ligand 2; butyrophilin B7-DC; programmed death ligand 2; B7DC; PD-L2; PDCD1L2; MGC142238; MGC142240;
PDCD2
programmed cell death 2
PDCD2;programmed cell death 2;programmed cell death protein 2;RP8;ZMYND7;zinc finger protein Rp-8;zinc finger MYND domain-containing protein 7;MGC12347;
PDCD4
programmed cell death 4 (neoplastic transformation inhibitor)
PDCD4; programmed cell death 4 (neoplastic transformation inhibitor); H731; programmed cell death protein 4; protein 197/15a; nuclear antigen H731; neoplastic transformation inhibitor protein;
PDCD5
programmed cell death 5
PDCD5; programmed cell death 5; programmed cell death protein 5; MGC9294; TF1 cell apoptosis related gene 19; TFAR19; TFAR19 novel apoptosis related; TFAR19 novel apoptosis-related; TF1 cell apoptosis-related gene 19; TF-1 cell apoptosis-related protein 1;
PDCD6
programmed cell death 6
PDCD6; programmed cell death 6; programmed cell death protein 6; ALG 2; apoptosis linked gene 2; PEF1B; apoptosis-linked gene-2; apoptosis-linked gene 2 protein; probable calcium-binding protein ALG-2; ALG-2; MGC9123; FLJ46208; MGC111017; MGC119050;
PDCD6IP
programmed cell death 6 interacting protein
PDCD6IP; programmed cell death 6 interacting protein; AIP1; ALIX; HP95; DRIP4; programmed cell death 6-interacting protein; PDCD6-interacting protein; ALG-2 interacting protein 1; ALG-2-interacting protein X; dopamine receptor interacting protein 4; apoptosis-linked gene 2-interacting protein X;
Pdgfa
platelet-derived growth factor alpha polypeptide
PDGFA; platelet-derived growth factor alpha polypeptide; PDGF1; PDGF-A; PDGF A-chain; platelet-derived growth factor alpha chain; Platelet-derived growth factor subunit A; PDGF subunit A; Platelet-derived growth factor A chain; PDGF-1; OTTHUMP00000199955; OTTHUMP00000199956; platelet-derived growth factor alpha isoform 2 preproprotein;
PDGFB
platelet-derived growth factor beta polypeptide
PDGFB; platelet-derived growth factor beta polypeptide; SIS; SSV; IBGC5; PDGF2; c-sis; PDGF-2; platelet-derived growth factor subunit B; becaplermin; PDGF, B chain; PDGF subunit B; proto-oncogene c-Sis; platelet-derived growth factor 2; platelet-derived growth factor B chain; platelet-derived growth factor, beta polypeptide (oncogene SIS); platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog);
PDGFC
platelet derived growth factor C
PDGFC; platelet derived growth factor C; platelet-derived growth factor C; fallotein; SCDGF; PDGF-C; VEGF-E; spinal cord-derived growth factor; secretory growth factor-like protein; AI647969; 1110064L01Rik;
PDGFD
platelet derived growth factor D
PDGFD; platelet derived growth factor D; platelet-derived growth factor D; IEGF; MSTP036; SCDGF B; spinal cord derived growth factor B; PDGF-D; iris-expressed growth factor; spinal cord-derived growth factor B; spinal cord-derived growth factor-B; SCDGFB; SCDGF-B;
PDGFRA
platelet-derived growth factor receptor, alpha polypeptide
PDGFRA; platelet-derived growth factor receptor, alpha polypeptide; platelet-derived growth factor receptor alpha; CD140a; PDGFR2; PDGFR-alpha; PDGF-R-alpha; CD140a antigen; PDGFRA/BCR fusion; CD140 antigen-like family member A; platelet-derived growth factor receptor 2; alpha-type platelet-derived growth factor receptor; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein; CD140A; PDGFR-2; RHEPDGFRA; MGC74795;
PDGFRB
platelet derived growth factor receptor, beta polypeptide
PDGFRB; platelet derived growth factor receptor, beta polypeptide; beta-type platelet-derived growth factor receptor; CD140B; Beta platelet derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD 140B; CD140 antigen-like family member B; CD140b antigen; JTK12; OTTHUMP00000160528; PDGF R beta; PDGF-R-beta; PDGFR; PDGFR1; PDGFRB; PGFRB_HUMAN; Platelet derived growth factor receptor beta; Platelet derived growth factor receptor beta polypeptide; PDGF-R-beta; PDGF beta chain; OTTMUSP00000015854; OTTMUSP00000015855; CD140 antigen-like family member B; platelet-derived growth factor receptor beta variant 1; Pdgfr; CD140b; AI528809;
Pgf
placental growth factor
PGF; placental growth factor; PGFL; PLGF; PlGF-2; D12S1900; SHGC-10760; placenta growth factor; placental growth factor, vascular endothelial growth factor-related protein;
PIM2
proviral integration site 2
PIM2; proviral integration site 2; serine/threonine-protein kinase pim-2; Pim-2; DXCch3;
PLA2G10
phospholipase A2, group X
PLA2G10; phospholipase A2, group X; group 10 secretory phospholipase A2; GXPLA2; Group X secretory phospholipase A2; GXSPLA2; Phosphatidylcholine 2 acylhydrolase GX; Phospholipase A2 group X; SPLA2; sPLA2X; sPLA2-X; GX sPLA2; OTTHUMP00000045725; phosphatidylcholine 2-acylhydrolase 10;
PLA2G12A
phospholipase A2, group XIIA
PLA2G12A; phospholipase A2, group XIIA; phospholipase A2, group XII , PLA2G12; group XIIA secretory phospholipase A2; EC 3.1.1.4; Group XIIA secretory phospholipase A2 precursor; GXII sPLA2; Phosphatidylcholine 2 acylhydrolase GXII; Phospholipase A2 group XIIA; PLA2G12; sPLA2-XII; group XII secreted phospholipase A2; group XIIA secreted phospholipase A2; phosphatidylcholine 2-acylhydrolase 12A; GXII; ROSSY;
PLA2G16
phospholipase A2, group XVI
PLA2G16; phospholipase A2, group XVI; HRAS like suppressor 3 , HRASLS3; group XVI phospholipase A2; adipose specific PLA2; AdPLA; H REV107 1; HREV107; HREV107 3; MGC118754.; Adipose specific phospholipase A2; H rev 107 protein homolog; HRAS like suppressor 3; Renal carcinoma antigen NY REN 65; OTTHUMP00000237069; adipose-specific PLA2; HRAS-like suppressor 1; HRAS-like suppressor 3; H-rev 107 protein homolog; Ca-independent phospholipase A1/2; adipose-specific phospholipase A2; renal carcinoma antigen NY-REN-65; HRSL3; HRASLS3; HREV107-1; HREV107-3; H-REV107-1;
PLA2G1B
phospholipase A2, group IB (pancreas)
PLA2G1B; phospholipase A2, group IB (pancreas); PLA2, PLA2A, PPLA2; phospholipase A2; group IB phospholipase A2; phosphatidylcholine 2-acylhydrolase 1B; PLA2; PLA2A; PPLA2; MGC119834; MGC119835;
PLA2G2A
phospholipase A2, group IIA (platelets, synovial fluid)
PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid); phospholipase A2, membrane associated; GIIC sPLA2; enhancing factor; modifier of Min1; group IIA phospholipase A2; secretory group II phospholipase A2; phosphatidylcholine 2-acylhydrolase 2A; non-pancreatic secreted type II phospholipase A2; EF; Mom1; Pla2; sPLA2; sPla2-IIA;
PLA2G2D
phospholipase A2, group IID
PLA2G2D; phospholipase A2, group IID; group IID secretory phospholipase A2; sPLA2S; PLA2IID; sPLA2-IID; GIID sPLA2; secretory phospholipase A2s; phosphatidylcholine 2-acylhydrolase 2D; secretory-type PLA, stroma-associated homolog; SPLASH;
PLA2G2E
phospholipase A2, group IIE
PLA2G2E; phospholipase A2, group IIE; group IIE secretory phospholipase A2; 2IIE; EC 3.1.1.4; GIIE sPLA2; Group IIE secretory phospholipase A2 precursor; Phosphatidylcholine 2 acylhydrolase GIIE; Phosphatidylcholine 2-acylhydrolase 2E; Phospholipase A2 group IIE; sPLA; sPLA2-IIE;
PLA2G4A
phospholipase A2, group IVA (cytosolic, calcium-dependent)
PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent); PLA2G4; cytosolic phospholipase A2; cPLA2 alpha; cPLA2; lysophospholipase; phospholipase A2 group IVA; phosphatidylcholine 2-acylhydrolase; calcium-dependent phospholipid-binding protein; cPLA2-alpha; MGC126350;
PLA2G5
phospholipase A2, group V
PLA2G5; phospholipase A2, group V; calcium-dependent phospholipase A2; Ca2+ dependent phospholipase A2; Calcium dependent phospholipase A2; DKFZp686C2294; Group V phospholipase A2; GV PLA2; gVPLA2; hVPLA(2); MGC46205; OTTHUMP00000044655; PA2G5_HUMAN; Phosphatidylcholine 2 acylhydrolase; Phosphatidylcholine 2-acylhydrolase 5; Phospholipase A2 group V; PLA2 10; PLA2 G5; PLA2-10; sPLA2 Type V; OTTHUMP00000002785; Ca2+-dependent phospholipase A2; GV-PLA2;
PLA2G7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); platelet-activating factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIA-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIA phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2;
RERG
RAS-like, estrogen-regulated, growth inhibitor
RERG; RAS-like, estrogen-regulated, growth inhibitor; ras-related and estrogen-regulated growth inhibitor; MGC15754; RAS like estrogen regulated growth inhibitor; Ras related and estrogen regulated growth inhibitor; RERG_HUMAN; Weakly similar to N ras protein [H.sapiens];
SCG5
secretogranin V (7B2 protein)
SCG5; secretogranin V (7B2 protein); secretory granule, neuroendocrine protein 1 (7B2 protein) , SGNE1; neuroendocrine protein 7B2; 7B2; prohormone convertase chaperone; SgV; Pituitary polypeptide; Secretory granule endocrine protein I; 7B2 protein; APPG; P7B2; SCG 5; Secretogranin 5; Secretogranin V 7B2 protein; Secretogranin5; SecretograninV; Secretory granule neuroendocrine protein 1 7B2 protein; Secretory granule neuroendocrine protein 1; Sg V; SGNE 1; SGNE1; secretogranin-5; OTTHUMP00000215364; OTTHUMP00000215365; OTTHUMP00000215366; OTTHUMP00000215367; OTTHUMP00000215368; secretory granule, neuroe;
SELP
selectin P (granule membrane protein 140kDa, antigen CD62)
SELP; selectin P (granule membrane protein 140kDa, antigen CD62); GRMP, selectin P (granule membrane protein 140kD, antigen CD62); P-selectin; CD62; CD62P; GMP140; PADGEM; PSEL; GMP-140; granule membrane protein 140; granulocyte membrane protein; CD62 antigen-like family member P; platelet alpha-granule membrane protein; leukocyte-endothelial cell adhesion molecule 3; platelet activation dependent granule-external membrane protein; GRMP; LECAM3; FLJ45155;
SSB
Sjogren syndrome antigen B (autoantigen La)
La; LARP3; La/SSB; La/SSB (Autoimmune RNA Protein); SSB; Sjogren syndrome antigen B (autoantigen La);
TDGF1
teratocarcinoma-derived growth factor 1
TDGF1; teratocarcinoma-derived growth factor 1; CR; CRGF; CRIPTO; cripto-1 growth factor; epidermal growth factor-like cripto protein CR1;
Tgfb1
Transforming Growth Factor, Beta 1
Tgfb1; transforming growth factor, beta 1; CED; LAP; DPD1; TGFB; TGFbeta; TGF-beta 1 protein; latency-associated peptide; Camurati-Engelmann disease; Transforming growth factor beta-1; TGF-beta-1; Camui Engelmann disease; Diaphyseal dysplasia 1 progressive; TGF beta 1; TGF beta; TGF beta 1 protein; TGF-beta-5; TGF-beta1; Tgfb-1; TGFB1_HUMAN; TGFbeta1; Transforming Growth Factor b1; Transforming Growth Factor beta 1; Transforming growth factor beta 1a;
TGFB2
transforming growth factor, beta 2
TGFB2; transforming growth factor, beta 2; transforming growth factor beta-2; G-TSF; cetermin; polyergin; BSC-1 cell growth inhibitor; glioblastoma-derived T-cell suppressor factor; TGF-beta2; MGC116892; LDS4;
TGFB3
transforming growth factor, beta 3
TGFB3; transforming growth factor, beta 3; ARVD; FLJ16571; TGF-beta3; transforming growth factor beta-3; TGF-beta-3; MGC105479; MGC118722; TGF beta 3; TGF beta3; TGFB 3; TGFB3_HUMAN; transforming growth factor beta 3; OTTHUMP00000246179; OTTHUMP00000246180;
TGFBI
TGFBI transforming growth factor, beta-induced, 68kDa
TGFBI; transforming growth factor, beta-induced, 68kDa; CSD1, CSD2, CSD3, LCD1, transforming growth factor, beta induced, 68kD; transforming growth factor-beta-induced protein ig-h3; BIGH3; CDB1; CDGG1; RGD-CAP; beta ig-h3; kerato-epithelin; RGD-containing collagen-associated protein; CSD; CDG2; CSD1; CSD2; CSD3; EBMD; LCD1;
TGFBR1
transforming growth factor, beta receptor 1
TGFBR1; transforming growth factor, beta receptor 1; transforming growth factor, beta receptor I (activin A receptor type II like kinase, 53kD); TGF-beta receptor type-1; activin A receptor type II like kinase; 53kDa; ACVRLK4; ALK 5; tbetaR-I; TGF-beta re;
TGFBR2
transforming growth factor, beta receptor II (70/80kDa)
TGFBR2; transforming growth factor, beta receptor II (70/80kDa); AAT3; FAA3; LDS2; MFS2; RIIC; LDS1B; LDS2B; TAAD2; TGFR-2; TGFbeta-RII; TGF-beta receptor type-2; tbetaR-II; TGF-beta type II receptor; TGF-beta receptor type IIB; transforming growth factor beta receptor type IIC; transforming growth factor, beta receptor II beta; transforming growth factor, beta receptor II alpha; transforming growth factor, beta receptor II delta; transforming growth factor, beta receptor II gamma; transforming growth factor, beta receptor II epsilon;
TGFBR3
transforming growth factor, beta receptor III
TGFBR3; transforming growth factor, beta receptor III; transforming growth factor, beta receptor III (betaglycan, 300kDa); transforming growth factor beta receptor type 3; betaglycan; betaglycan proteoglycan; BGCAN; TGFR-3; TGF-beta receptor type 3; TGF-b;
VEGF
vascular endothelial growth factor
MGC70609; Vascular endothelial growth factor; Vascular endo-thelial growth factor A; Vascular Permeability Factor; VEGF-A; VEGFA; VEG-FA_HUMAN; VPF; PIGF; Plgf; AI854365; VEGFD; VEGF-D; FIGF; VRP; Flt4-L; VEGFC; VEGF-C; Vascular endothelial growth factor D; c-Fos-induced growth factor; vascular endothelial growth factor B; vascular endothelial growth factor C; Flt4 ligand; Vascular endothelial growth factor-related protein; VRF; VEGFL; VEGF-B; VEGFB; VEGF-related factor; OTTHUMP00000022960; c-fos induced growth factor (vascular endothelial growth factor D); OT-THUMP00000218843; FLT4 ligand DHM; OT-THUMP00000236927; OTTHUMP00000236928;
Vegfa
vascular endothelial growth factor A
VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor; Vegf120; Vegf164; Vegf188;
VEGFB
vascular endothelial growth factor B
VEGFB; vascular endothelial growth factor B; VEGF-related factor; Vrf; VEGF-B;
VEGFC
vascular endothelial growth factor C
VEGFC; vascular endothelial growth factor C; VRP; Flt4-L; FLT4 ligand DHM; vascular endothelial growth factor-related protein; VEGF-C; AW228853;
VEGFD
c-fos induced growth factor (vascular endothelial growth factor D)
FIGF; c-fos induced growth factor (vascular endothelial growth factor D); VEGFD; VEGF-D; vascular endothelial growth factor D; c-fos-induced growth factor; OTTHUMP00000022960 ;
WNT1
wingless-type MMTV integration site family, member 1
WNT1; wingless-type MMTV integration site family, member 1; INT1; OI15; BMND16; proto-oncogene Wnt-1; proto-oncogene Int-1 homolog; wingless-type MMTV integration site family, member 1 (oncogene INT1);
WNT3A
wingless-type MMTV integration site family, member 3A
WNT3A; wingless-type MMTV integration site family, member 3A; protein Wnt-3a; MGC119418; MGC119419; MGC119420;
Wnt5a
wingless-type MMTV integration site family, member 5A
WNT5A; wingless-type MMTV integration site family, member 5A; protein Wnt-5a; hWNT5A; WNT 5A protein; WNT-5A protein;
ITGB2
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
95 subunit beta; Beta 2 (antigen CD18 (p95); CD 18; CD18; CD18 antigen; Cell surface adhesion glycoprotein LFA 1/CR3/P150, 959 beta subunit precursor); Cell surface adhesion glycoproteins LFA 1/CR3/p150 95 subunit beta; Cell surface adhesion glycoproteins LFA 1/CR3/p150, 95 subunit beta; Cell surface adhesion glycoproteins LFA 1/CR3/p15095 beta subunit; Cell surface adhesion glycoproteins LFA-1/CR3/p150; Complement component 3 receptor 3 and 4 subunit; Complement receptor C3 beta subunit; Complement receptor C3 subunit beta; Integrin beta 2; Integrin beta chain beta 2; Integrin beta-2; Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); ITB2_HUMAN; ITGB 2; ITGB2; LAD; LCAMB; Leukocyte associated antigens CD18/11A, CD18/11B, CD18/11C; Leukocyte Cell Adhesion Molecule CD18; LFA 1; LFA1; Lymphocyte function associated antigen 1; MAC 1; MAC1; Macrophage antigen 1 (mac1) beta subunit; MF17; MFI7; LFA-1; MAC-1;
ITGB1
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
CD29; FNRB; MDF2; VLAB; GPIIA; MSK12; VLA-BETA; integrin beta-1 (avian); ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12);
ITGA2B
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); GT; GTA; CD41; GP2B; HPA3; CD41B; GPIIb; BDPLT2; BDPLT16; integrin alpha-IIb; GPalpha IIb; platelet-specific antigen BAK; platelet membrane glycoprotein IIb; platelet fibrinogen receptor, alpha subunit;
NR2F2
NR2F2 nuclear receptor subfamily 2, group F, member 2
NR2F2; nuclear receptor subfamily 2, group F, member 2; ARP1, TFCOUP2; COUP transcription factor 2; COUP TFII; COUPTFB; NF E3; SVP40; COUP transcription factor II; apolipoprotein AI regulatory protein 1; apolipoprotein A-I regulatory protein 1; ADP-ribosylation factor related protein 1; chicken ovalbumin upstream promoter transcription factor 2; chicken ovalbumin upstream promoter-transcription factor I; chicken ovalbumin upstream promoter-transcription factor II variant 1; chicken ovalbumin upstream promoter-transcription factor II variant 2; chicken ovalbumin upstream promoter-transcription factor II variant 3; ARP1; NF-E3; NR2F1; TFCOUP2; COUPTFII; MGC117452;
ITGAX
integrin, alpha X (complement component 3 receptor 4 subunit)
ITGAX; integrin, alpha X (complement component 3 receptor 4 subunit); CD11C; SLEB6;
ITGB3
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
GT; CD61; GP3A; BDPLT2; GPIIIa; integrin beta-3; platelet glycoprotein IIIa; platelet membrane glycoprotein IIIa; CD41; CD41b; GP 2B; GP IIb; GTA; HPA3; Integrin alpha 2b; ITGA2B; ITGB3; Tadocizumab; 339086-80-5;
ITGA6
integrin, alpha 6
ITGA6; integrin, alpha 6; integrin alpha-6; CD49f; integrin alpha6B; CD49 antigen-like family member F; VLA-6; ITGA6B; FLJ18737; DKFZp686J01244;
PMS2
PMS2 postmeiotic segregation increased 2
PMS2; PMS2 postmeiotic segregation increased 2 (S. cerevisiae); PMSL2, postmeiotic segregation increased (S. cerevisiae) 2; mismatch repair endonuclease PMS2; H_DJ0042M02.9; HNPCC4; PMS1 protein homolog 2; DNA mismatch repair protein PMS2; PMSL2; PMS2CL;
CR1
CR1 complement component (3b/4b) receptor 1 (Knops blood group)
CR1; complement component (3b/4b) receptor 1 (Knops blood group); complement component (3b/4b) receptor 1, including Knops blood group system; complement receptor type 1; CD35; KN; CD35 antigen; C3b/C4b receptor; C3-binding protein; Knops blood group antigen; complement component receptor 1; C3BR; C4BR;
ITGA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor); CD49B; integrin alpha-2; CD49b; integrin alpha 2; collagen receptor; VLA-2 subunit alpha; platelet antigen Br; platelet glycoprotein Ia; platelet glycoprotein GPIa; CD49 antigen-like fam;
ITGA5
integrin alpha 5 (fibronectin receptor alpha)
ITGA5; integrin alpha 5 (fibronectin receptor alpha); integrin alpha-5; integrin alpha-F; CD49 antigen-like family member E; fibronectin receptor subunit alpha; fibronectin receptor alpha polypeptide; Fnra; VLA5; Cd49e;
ITGAE
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
ITGAE; integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide); integrin alpha-E; CD103; HUMINAE; HML-1 antigen; integrin alpha-IEL; mucosal lymphocyte 1 antigen; antigen CD103, human mucosal lymphocyte antigen 1; alpha po;
GAP43
Gap43 growth associated protein 43
GAP43; growth associated protein 43; neuromodulin; growth-associated protein 43; axonal membrane protein GAP-43; growth accentuating protein 43; calmodulin-binding protein P-57; brain abundant, membrane attached signal protein 2; B-50; Basp2; GAP-43;
HMGA1
high mobility group AT-hook 1
HMGA1; high mobility group AT-hook 1; high mobility group (nonhistone chromosomal) protein isoforms I and Y , HMGIY; high mobility group protein HMG-I/HMG-Y; HMG-I(Y); high mobility group protein R; high mobility group protein A1; nonhistone chromosomal h;
HMGB2
high mobility group box 2
HMGB2; high mobility group box 2; high mobility group (nonhistone chromosomal) protein 2 , high mobility group box 2 , HMG2; high mobility group protein B2; HMG-2; high-mobility group box 2; high mobility group protein 2; high-mobility group (nonhistone;
IGFPB2
Insulin-Like Growth Factor Binding Protein 2, 36kDa
BP2; IBP2; IBP-2; IGF-binding protein 2; IGFBP2; IGFBP-2; IGF-BP53; insulin-like growth factor binding protein 2 (36kD); insulin-like growth factor binding protein 2, 36kDa; insulin-like growth factor-binding protein 2; OTTHUMP00000207751; OTTHUMP00000207753.;
IGFPB6
Insulin-Like Growth Factor Binding Protein 6
IGFBP6; insulin-like growth factor binding protein 6; IBP6; IGF binding protein 6; Insulin-like growth factor-binding protein 6; IGF-binding protein 6; IGFBP-6; IBP-6;
BANF1
barrier to autointegration factor 1
BANF1; barrier to autointegration factor 1; barrier-to-autointegration factor; BAF; breakpoint cluster region protein 1; NGPS; BCRP1; D14S1460; MGC111161;
C4B
complement component 4B (Chido blood group)
C4b Binding Protein; C4B; complement component 4B (Chido blood group); complement component 4B (Chido blood group);
CGREF1
cell growth regulator with EF-hand domain 1
CGREF1; cell growth regulator with EF-hand domain 1; cell growth regulator with EF hand domain protein 1; CGR11; Cell growth regulator with EF hand domain 1; Cell growth regulatory gene 11; Cell growth regulatory gene 11 protein; CGR 11; CGREF 1; hydrophobestin; OTTHUMP00000200952; OTTHUMP00000200954; OTTHUMP00000200955; OTTHUMP00000200956; OTTHUMP00000200957;
CSE1L
CSE1 chromosome segregation 1-like
CSE1L; CSE1 chromosome segregation 1-like (yeast); chromosome segregation 1 (yeast homolog) like; exportin-2; CAS; CSE1; XPO2; exp2; importin-alpha re-exporter; chromosome segregation 1-like protein; cellular apoptosis susceptibility protein; MGC117283; M;
EDEM2
ER degradation enhancer, mannosidase alpha-like 2
EDEM2; ER degradation enhancer, mannosidase alpha-like 2; C20orf31, C20orf49, chromosome 20 open reading frame 31; ER degradation-enhancing alpha-mannosidase-like 2; bA4204.1; FLJ10783; C20orf49; EDEM 2; EDEM2_HUMAN; ER degradation enhancer mannosidase alpha like 2; ER degradation enhancing alpha mannosidase like 2; ER degradation enhancing mannosidase like protein 2; OTTHUMP00000030728; ER degradation-enhancing-mannosidase-like protein 2; C20orf31;
EPS15L1
epidermal growth factor receptor pathway substrate 15-like 1
EPS15L1; epidermal growth factor receptor pathway substrate 15-like 1; epidermal growth factor receptor substrate 15-like 1; eps15R; eps15-related protein; epidermal growth factor receptor substrate EPS15R;
ERCC6L
excision repair cross-complementing rodent repair deficiency, complementation group 6-like
ERCC6L; excision repair cross-complementing rodent repair deficiency, complementation group 6-like; DNA excision repair protein ERCC-6-like; FLJ20105; PICH; PLK1 interacting checkpoint helicase; tumor antigen BJ-HCC-15; SNF2/RAD54 family protein; ATP-dependent helicase ERCC6-like; excision repair protein ERCC6-like; Plk1-interacting checkpoint helicase; excision repair cross-complementing rodent repair deficiency complementation group 6 - like; MGC131695;
ERCC8
excision repair cross-complementing rodent repair deficiency, complementation group 8
ERCC8; excision repair cross-complementing rodent repair deficiency, complementation group 8; CKN1, Cockayne syndrome 1 (classical); DNA excision repair protein ERCC-8; CSA; Cockayne syndrome WD-repeat protein CSA; cockayne syndrome WD repeat protein CSA;
ERMAP
erythroblast membrane-associated protein (Scianna blood group)
ERMAP; erythroblast membrane-associated protein (Scianna blood group); erythroblast membrane associated protein , erythroblast membrane associated protein (RD and SC blood groups) , Radin blood group , RD, SC, Scianna blood group; erythroid membrane-associated protein; ERMAP_HUMAN; Erythroblast membrane associated protein; Erythroid membrane associated protein; hERMAP; MGC118810; MGC118811; MGC118812; MGC118813; PRO2801; Radin blood group (Rd); Radin blood group antigen; RD; SC; Scianna blood group (Sc); Scianna blood group antigen; OTTHUMP00000008916; OTTHUMP00000008917; OTTHUMP00000008918;
EVI2B
ecotropic viral integration site 2B
EVI2B; ecotropic viral integration site 2B; protein EVI2B; CD361; D17S376; EVDB; EVI-2B; ecotropic viral integration site 2B protein homolog;
FANCC
Fanconi anemia, complementation group C
FANCC; Fanconi anemia, complementation group C; FACC; Fanconi anemia group C protein; FA3; FAC; FLJ14675;
FANCG
Fanconi anemia, complementation group G
FANCG; Fanconi anemia, complementation group G; FAG; XRCC9; Fanconi anemia group G protein; DNA repair protein XRCC9; X-ray repair, complementing defective, in Chinese hamster, 9; X-ray repair complementing defective repair in Chinese hamster cells 9;
FLI1
Friend leukemia virus integration 1
FLI1; Friend leukemia virus integration 1; Friend leukemia integration 1 transcription factor; EWSR2; SIC 1; proto-oncogene Fli-1; transcription factor ERGB; SIC-1;
FLVCR1
feline leukemia virus subgroup C cellular receptor 1
FLVCR1; feline leukemia virus subgroup C cellular receptor 1; PCA; AXPC1; FLVCR; PCARP; MFSD7B; feline leukemia virus subgroup C receptor-related protein 1;
FRS2
fibroblast growth factor receptor substrate 2
FRS2; fibroblast growth factor receptor substrate 2; FRS2A; FRS2alpha; SNT 1; SNT1; FGFR signaling adaptor SNT; FGFR signalling adaptor; FGFR substrate 2; FGFR-signaling adaptor SNT; FRS 2; FRS2_HUMAN; SNT; SNT-1; Suc 1 Associated Neurotrophic Factor Target; Suc1 associated neurotrophic factor target 1; Suc1-associated neurotrophic factor target 1;
GAB2
GRB2-associated binding protein 2
GAB2; GRB2-associated binding protein 2; GRB2-associated-binding protein 2; Grb2 associated binder 2; KIAA0571; pp100; Grb2-associated binder 2; growth factor receptor bound protein 2-associated protein 2;
GAS2
growth arrest-specific 2
GAS2; growth arrest-specific 2; growth arrest-specific protein 2; GAS-2; MGC32610;
GAS2L3
growth arrest-specific 2 like 3
GAS2L3; growth arrest-specific 2 like 3; GAS2-like protein 3; GAS2 like protein 3; Gm240; Growth arrest specific 2 like 3; Growth arrest specific protein 2 like 3; OTTHUMP00000243791; OTTHUMP00000243792; growth arrest-specific protein 2-like 3; G2L3;
GDF7
growth differentiation factor 7
GDF7; growth differentiation factor 7; growth/differentiation factor 7; BMP12; bone morphogenetic protein 12; GDF-7; GDF7_HUMAN; OTTHUMP00000115986;
GFI1
growth factor independent 1 transcription repressor
GFI1; growth factor independent 1 transcription repressor; SCN2; GFI-1; GFI1A; ZNF163; zinc finger protein Gfi-1; zinc finger protein 163; growth factor independence-1; growth factor independent protein 1;
GOLGB1
golgin B1, golgi integral membrane protein
GOLGB1; golgin B1, golgi integral membrane protein; Golgin subfamily B member 1; Golgi complex associated protein 372kDa; Golgi complex-associated protein 372kDa; Macrogolgin; 372 kDa Golgi complex associated protein; GCP; GCP372; GIANTIN; Golgi autoantigen golgin subfamily a member 1; Golgi autoantigen golgin subfamily b macrogolgin (with transmembrane signal) 1; Golgi autoantigen, golgin subfamily b, macrogolgin 1; Golgin B1; GOLIM1; MGC33154; golgi-associated protein GCP360;
GOLIM4
golgi integral membrane protein 4
GOLIM4; golgi integral membrane protein 4; golgi phosphoprotein 4 , GOLPH4; GIMPC; GPP130; P138; 130 kDa golgi localized phosphoprotein; cis Golgi localized calcium binding protein; Golgi phosphoprotein 4; GOLPH 4; GPP 130; P 138; type II Golgi membrane protein; OTTHUMP00000213059; OTTHUMP00000213060; golgi phosphoprotein of 130 kDa; golgi integral membrane protein, cis; 130 kDa golgi-localized phosphoprotein; golgi-localized phosp; GOLPH4;
GRHL3
grainyhead-like 3 (Drosophila)
GRHL3; grainyhead-like 3 (Drosophila); TFCP2L4, transcription factor CP2 like 4; grainyhead-like protein 3 homolog; SOM; Drosophila; Grainyhead like 3; Grainyhead like protein 3 homolog; Sister of mammalian grainyhead protein; TFCP2L4; Transcription factor CP2 like 4; OTTHUMP00000003072; OTTHUMP00000003297; OTTHUMP00000003298; OTTHUMP00000234795; transcription factor hSOM1; sister of mammalian grainyhead; sister-of-mammalian grainyhead; transcription factor CP2-like 4;
GRIA3
Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3)
GRIA3; glutamate receptor, ionotropic, AMPA3 (alpha 3); glutamate receptor 3; glutamate receptor subunit 3; AMPA-selective glutamate receptor 3; glutamate receptor ionotropic, AMPA 3; glutamate receptor channel alpha3 subunit; GluA3; Glur3; GluR-C; Glur-3; GluR-K3; mKIAA4184; Gluralpha3; 2900064I19Rik; KIAA4184;
GSR
glutathione reductase
GSR; glutathione reductase; HEL-75; glutathione reductase, mitochondrial; GR; GRase; epididymis luminal protein 75;
GZMM
granzyme M (lymphocyte met-ase 1)
GZMM; granzyme M (lymphocyte met-ase 1); granzyme M; LMET1; lymphocyte met ase 1; MET1; Granzyme M (lymphocyte met ase 1); GranzymeM; GZM M; HU Met 1; LMET 1; MET 1; Met 1 serine protease; Met ase; Met1 serine protease; Natural killer cell granular protease; met-ase; HU-Met-1; lymphocyte met-ase 1; Met-1 serine protease;
HDGFRP3
hepatoma-derived growth factor, related protein 3
HDGFRP3; hepatoma-derived growth factor, related protein 3; hepatoma-derived growth factor-related protein 3; HRP-3; 2700022B06Rik;
HGS
hepatocyte growth factor-regulated tyrosine kinase substrate
HGS; hepatocyte growth factor-regulated tyrosine kinase substrate; Hrs; Vps27; ZFYVE8; protein pp110; human growth factor-regulated tyrosine kinase substrate; FLJ11421; FLJ39878;
HMGA2
high mobility group AT-hook 2
HMGA2; high mobility group AT-hook 2; high mobility group (nonhistone chromosomal) protein isoform I C , HMGIC; high mobility group protein HMGI-C; BABL; LIPO; High-mobility group protein HMGI-C; high mobility group AT-hook protein 2; high-mobility group;
HMGB3
high mobility group box 3
HMGB3; high mobility group box 3; high mobility group (nonhistone chromosomal) protein 4 , high mobility group box 3 , HMG4; high mobility group protein B3; HMG2A; MGC90319; non histone chromosomal protein; High mobility group protein 2a; High mobility group protein HMG4; HMG 4; HMGB 3; Nonhistone chromosomal protein HMG4; high-mobility group box 3; high mobility group protein 4; non-histone chromosomal protein; high-mobility group (nonhistone chromosomal) protein 4; HMG4; HMG-4; HMG-2a;
ING3
inhibitor of growth family, member 3
ING3; inhibitor of growth family, member 3; inhibitor of growth protein 3; Eaf4; FLJ20089; MEAF4; p47ING3; ING2;
INTS6
integrator complex subunit 6
INTS6; integrator complex subunit 6; DDX26, DEAD/H (Asp Glu Ala Asp/His) box polypeptide 26; DBI 1; DDX26A; DICE1; HDB; INT6; Notchl2; DBI-1; DBI1; DDX26; DEAD box protein; DEAD/H (Asp Glu Ala Asp/His) box polypeptide 26; Deleted in cancer 1; DKFZp434B105; INT6_HUMAN; INTS 6; OTTHUMP00000018439; OTTHUMP00000215034; OTTHUMP00000215036; Protein DDX26; Protein deleted in cancer 1; RNA helicase HDB; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26;
ITFG2
integrin alpha FG-GAP repeat containing 2
ITFG2; integrin alpha FG-GAP repeat containing 2; integrin-alpha FG-GAP repeat-containing protein 2; MDS028; Integrin alpha FG GAP repeat containing 2; Integrin alpha FG GAP repeat containing protein 2; ITFG 2; ITFG2_HUMAN; MDS 028; RGD1311944; Uncharacterized hematopoietic stem/progenitor cells protein MDS028; OTTHUMP00000161190;
ITFG3
integrin alpha FG-GAP repeat containing 3
ITFG3; integrin alpha FG-GAP repeat containing 3; C16orf9, chromosome 16 open reading frame 9; protein ITFG3; DKFZP761D0211; FLJ32603; AI429612; Chromosome 16 open reading frame 9; gs19; ITFG3_HUMAN; MGC93756; OTTHUMP00000067161; RGD1311484; OTTHUMP00000067159; OTTHUMP00000067160; C16orf9;
ITGA9
integrin, alpha 9
ITGA9; integrin, alpha 9; RLC; ITGA4L; ALPHA-RLC; integrin alpha-9; integrin alpha-RLC;
ITGB3BP
integrin beta 3 binding protein (beta3-endonexin)
ITGB3BP; integrin beta 3 binding protein (beta3-endonexin); centromere protein R; CENPR; HSU37139; NRIF3; TAP20; Beta3 endonexin; CENP R; Integrin beta 3 binding protein; NRIF 3; Nuclear receptor interacting factor 3; TAP 20; beta 3 endonexin; beta-3-endonexin; OTTHUMP00000015392; OTTHUMP00000015409; OTTHUMP00000015410; integrin beta-3-binding protein; nuclear receptor-interacting factor 3; CENP-R;
ITGB7
integrin, beta 7
ITGB7; integrin, beta 7; integrin beta-7; Gut homing receptor beta subunit; Integrin beta 7 subunit; Integrin beta-P; ITB7; ITB7_HUMAN; Ly69; M290 IEL antigen; OTTHUMP00000242064; OTTHUMP00000242065; OTTHUMP00000242066;
NEGR1
neuronal growth regulator 1
NEGR1; neuronal growth regulator 1; a kindred of IgLON; IgLON family member 4; IGLON4; KILON; MGC46680; neurotractin; Ntra; PRO4993; UNQ2433; DMML2433;
NGFRAP1
nerve growth factor receptor (TNFRSF16) associated protein 1
NGFRAP1; nerve growth factor receptor (TNFRSF16) associated protein 1; protein BEX3; Bex; BEX3; brain expressed; X linked 3; DXS6984E; HGR74; NADE; brain expressed, X-linked 3; brain-expressed X-linked protein 3; ovarian granulosa cell protein (13kD); p75NTR-associated cell death executor; ovarian granulosa cell 13.0 kDa protein HGR74; nerve growth factor receptor-associated protein 1;
NODAL
nodal growth differentiation factor
NODAL; nodal growth differentiation factor; HTX5; nodal homolog;
NR1D1
NR1D1 nuclear receptor subfamily 1, group D, member 1
NR1D1; nuclear receptor subfamily 1, group D, member 1; THRAL; nuclear receptor subfamily 1 group D member 1; ear 1; hRev; Rev ErbAalpha; THRA1; Rev-ErbAalpha; rev-erbA-alpha; V-erbA-related protein 1; nuclear receptor Rev-ErbA-alpha; EAR1; ear-1;
NR2C2
NR2C2 nuclear receptor subfamily 2, group C, member 2
NR2C2; nuclear receptor subfamily 2, group C, member 2; TR4; nuclear receptor subfamily 2 group C member 2; hTAK1; TAK1; TR2R1; testicular receptor 4; orphan nuclear receptor TR4; Nuclear hormone receptor TR4; TR4 nuclear hormone receptor; orphan nuclear receptor TAK1; testicular nuclear receptor 4;
NR2E1
NR2E1 nuclear receptor subfamily 2, group E, member 1
NR2E1; nuclear receptor subfamily 2, group E, member 1; TLX; nuclear receptor subfamily 2 group E member 1; TLL; XTLL; hTll; tailless homolog; nuclear receptor TLX; tailes-related receptor; protein tailless homolog;
NR2E3
nuclear receptor subfamily 2, group E, member 3
NR2E3; nuclear receptor subfamily 2, group E, member 3; photoreceptor-specific nuclear receptor; PNR; rd7; RP37; ESCS; MGC49976; NR2 E3; Nuclear receptor subfamily 2 group E member 3; Photoreceptor specific nuclear receptor; Rd 7; Retina specific nuclear receptor; Retinal degeneration 7; RNR; retina-specific nuclear receptor; photoreceptor cell-specific nuclear receptor variant 1;
NR4A1
nuclear receptor subfamily 4, group A, member 1
NR4A1; nuclear receptor subfamily 4, group A, member 1; nuclear receptor subfamily 4 group A member 1; hormone receptor; nuclear protein N10; orphan nuclear receptor HMR; nuclear hormone receptor NUR/77; Hmr; N10; TR3; Gfrp; Hbr1; NP10; TIS1; GFRP1; Hbr-1; NGFIB; nur77; NGFI-B;
NR4A2
nuclear receptor subfamily 4, group A, member 2
NR4A2; nuclear receptor subfamily 4, group A, member 2; NOT; RNR1; HZF-3; NURR1; TINUR; nuclear receptor subfamily 4 group A member 2; nuclear receptor related 1; T-cell nuclear receptor NOT; orphan nuclear receptor NR4A2; orphan nuclear receptor NURR1; intermediate-early receptor protein; immediate-early response protein NOT; nur related protein-1, human homolog of; transcriptionally-inducible nuclear receptor; NGFI-B/nur77 beta-type transcription factor homolog; transcriptionally inducible nuclear receptor related 1;
NR4A3
nuclear receptor subfamily 4, group A, member 3
NR4A3; nuclear receptor subfamily 4, group A, member 3; nuclear receptor subfamily 4 group A member 3; CHN; CSMF; MINOR; NOR1; Chondrosarcoma, extraskeletal myxoid, fused to EWS; Mitogen induced nuclear orphan receptor; Mitogen-induced nuclear orphan receptor; Neuron derived orphan receptor 1; Neuron derived orphan receptor; Neuron-derived orphan receptor 1; NR4A3_HUMAN; Nuclear hormone receptor NOR-1; Nuclear hormone receptor NOR1; TEC; Translocated in extraskeletal chondrosarcoma; OTTHUMP00000022774; OTTHUMP00000022775; OTTHUMP00000022776; cho;
PCGF2
polycomb group ring finger 2
PCGF2; polycomb group ring finger 2; MEL-18; RNF110; ZNF144; polycomb group RING finger protein 2; ring finger protein 110; zinc finger protein 144; DNA-binding protein Mel-18;
PDCD11
programmed cell death 11
PDCD11; programmed cell death 11; protein RRP5 homolog; ALG 4; KIAA0185; RRP5; apoptosis-linked gene 4; NF-kappa-B-binding protein; programmed cell death protein 11; ALG4; NFBP; ALG-4;
PDCD2L
programmed cell death 2-like
PDCD2L; programmed cell death 2-like; programmed cell death protein 2-like; MGC13096; MGC144595; Programmed cell death 2 like; Programmed cell death protein 2 like;
PDCD7
programmed cell death 7
PDCD7; programmed cell death 7; programmed cell death protein 7; ES18; HES18; U11/U12 snRNP 59K; apoptosis-related protein ES18; FLJ54213; MGC22015;
PGA3
pepsinogen 3, group I (pepsinogen A)
PGA3; pepsinogen 3, group I (pepsinogen A); pepsin A; DKFZp666J2410; pepsinogen 3 group I (pepsinogen A); Pepsinogen 3 group I; pepsinogen A3; OTTHUMP00000237816; OTTHUMP00000238421; PGA4; PGA5;
PGA5
pepsinogen 5, group I (pepsinogen A)
PGA5; pepsinogen 5, group I (pepsinogen A); pepsin A; Pepsinogen 5 group I; Pepsinogen A5; OTTHUMP00000237822; PGA3; PGA4;
PLA2G15
phospholipase A2, group XV
PLA2G15; phospholipase A2, group XV; LYPLA3, lysophospholipase 3 (lysosomal phospholipase A2); group XV phospholipase A2; GXVPLA2; LLPL; 1 O acylceramide synthase; ACS; DKFZp564A0122; LCAT like lysophospholipase; LPLA2; Lysophospholipase 3 (lysosomal phospholipase A2); Lysophospholipase 3; Lysosomal phospholipase A2; OTTHUMP00000174859; UNQ341/PRO540; 1-O-acylceramide synthase; LCAT-like lysophospholipase; LYPLA3;
PMS1
PMS1 postmeiotic segregation increased 1
PMS1; PMS1 postmeiotic segregation increased 1 (S. cerevisiae); PMSL1, postmeiotic segregation increased (S. cerevisiae) 1; PMS1 protein homolog 1; mismatch repair gene PMSL1; human homolog of yeast mutL; DNA mismatch repair protein PMS1; rhabdomyosarcom;
SH3GL2
SH3-domain GRB2-like 2
SH3GL2; SH3-domain GRB2-like 2; endophilin-A1; CNSA2; EEN B1; SH3D2A; SH3P4; endophilin-1; SH3 domain protein 2A; Endophilin A1 BAR domain; bA335L15.1 (SH3-domain GRB2-like 2); SH3 domain-containing GRB2-like protein 2; EEN-B1; FLJ20276; FLJ25015;
SH3GLB1
SH3-domain GRB2-like endophilin B1
SH3GLB1; SH3-domain GRB2-like endophilin B1; SH3 domain, GRB2 like, endophilin B1; endophilin-B1; Bif 1; CGI 61; KIAA0491; PPP1R70; protein phosphatase 1; regulatory subunit 70; Bax-interacting factor 1; SH3-containing protein SH3GLB1; SH3 domain-containi;
SLC4A1
solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)
SLC4A1; solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group); AE1, DI, EPB3, Waldner blood group , WD; band 3 anion transport protein; CD233; FR; Froese blood group; RTA1A; SW; Swann blood group; WR; Wright blood group; Solute carrier family 4 anion exchanger member 1; Solute carrier family 4 member 1; AE 1; AE1; Anion exchange protein 1; Anion exchanger 1; B3AT_HUMAN; BND3; DI; Diego blood group; EMPB3; EPB3; Erythrocyte membrane protein band 3; Erythroid anion exchange protein; Waldner blood group; WD; WD1; OTTHUMP00000210781; solute carrier fa;
SPI1
spleen focus forming virus (SFFV) proviral integration oncogene spi1
SPI1; spleen focus forming virus (SFFV) proviral integration oncogene spi1; transcription factor PU.1; 31 kDa transforming protein; hematopoietic transcription factor PU.1; OF; PU.1; SFPI1; SPI 1; SPI 1 proto oncogene; SPI A; SPI-1 proto-oncogene; 31 kDa-transforming protein; SPI-1; SPI-A;
SRCRB4D
scavenger receptor cysteine rich domain containing, group B (4 domains)
SRCRB4D; scavenger receptor cysteine rich domain containing, group B (4 domains); scavenger receptor cysteine-rich domain-containing group B protein; S4D SRCRB; scavenger receptor cysteine rich protein SRCRB S4D; SRCRB S4D; SSC4D; Scavenger receptor cysteine rich domain containing group B (4 domains); Scavenger receptor cysteine rich domain containing group B; S4-SRCRB; OTTHUMP00000161135; scavenger receptor cysteine-rich protein SRCRB-S4D; S4D-SRCRB; SRCRB-S4D;
SSSCA1
Sjogren syndrome/scleroderma autoantigen 1
SSSCA1; Sjogren syndrome/scleroderma autoantigen 1; Sjogrens syndrome/scleroderma autoantigen 1; Sjoegren syndrome/scleroderma autoantigen 1; p27; Autoantigen p27; 1500016H19Rik; C184L; centromeric autoantigen (27kD); OTTHUMP00000232769; OTTHUMP00000233069; OTTHUMP00000233071; Sjogrens syndrome/scleroderma autoantigen 1 homolog; SSA27_HUMAN;
TGFB1I1
transforming growth factor beta 1 induced transcript 1
TGFB1I1; transforming growth factor beta 1 induced transcript 1; HIC5; ARA55; HIC-5; TSC-5; transforming growth factor beta-1-induced transcript 1 protein; androgen receptor coactivator ARA55; hydrogen peroxide-inducible clone 5 protein; androgen receptor coactivator 55 kDa protein; androgen receptor-associated protein of 55 kDa;
TOE1
target of EGR1, member 1 (nuclear)
TOE1; target of EGR1, member 1 (nuclear); target of EGR1 protein 1; FLJ13949;
WNT10B
wingless-type MMTV integration site family, member 10B
WNT10B; wingless-type MMTV integration site family, member 10B; protein Wnt-10b; SHFM6; WNT 12; WNT-10B protein; WNT-12;
XPC
xeroderma pigmentosum, complementation group C
XPC; xeroderma pigmentosum, complementation group C; DNA repair protein complementing XP-C cells; RAD4; xeroderma pigmentosum group C protein; XPCC; p125; mutant xeroderma pigmentosum group C; XP3;
ZG16B
zymogen granule protein 16 homolog B (rat)
PAUF; JCLN2; HRPE773; PRO1567; zymogen granule protein 16 homolog B; OTTHUMP00000159184; jacalin-like lectin domain containing 2; pancreatic adenocarcinoma upregulated factor; zymogen granule protein 16 homolog B (rat); ZG16B;
SDHC
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
SDHC; succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa; PGL3, succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD; succinate dehydrogenase cytochrome b560 subunit, mitochondrial; QPs-1; integral membran;
GC
group-specific component (vitamin D binding protein)
GC; group-specific component (vitamin D binding protein); DBP; GRD3; VDBG; VDBP; DBP/GC; HEL-S-51; vitamin D-binding protein; VDB; gc-globulin; vitamin D-binding alpha-globulin; epididymis secretory protein Li 51;
ITM2B
integral membrane protein 2B
ITM2B; integral membrane protein 2B; BRI; E3 16; E25B; ABRI; ABri/ADan amyloid peptide; BRI 2; BRI2; BRICD 2B; BRICD2B; BRICHOS domain containing 2B; FBD; ITM 2B; ITM2B_HUMAN; Protein E25B; Transmembrane protein BRI; OTTHUMP00000018394; OTTHUMP00000018395; E3-16;
AQP1
aquaporin 1 (Colton blood group)
AQP1; aquaporin 1 (Colton blood group); aquaporin 1 (channel forming integral protein, 28kDa) , aquaporin 1 (channel forming integral protein, 28kDa, CO blood group) , CO, Colton blood group; aquaporin-1; CHIP28; aquaporin-CHIP; Colton blood group; urin;
BIN3
bridging integrator 3
BIN3; bridging integrator 3; BIN3_HUMAN; MGC14978; OTTHUMP00000225122; OTTHUMP00000225124; OTTHUMP00000225126;
ERCC4
excision repair cross-complementing rodent repair deficiency, complementation group 4
ERCC4; excision repair cross-complementing rodent repair deficiency, complementation group 4; XPF; DNA repair endonuclease XPF; RAD1; xeroderma pigmentosum; complementation group F; DNA excision repair protein ERCC-4; DNA repair protein complementing XP-F;
GRIPAP1
GRIP1 associated protein 1
GRIPAP1; GRIP1 associated protein 1; GRIP1-associated protein 1; GRASP-1; GRIP-associated protein 1; Grasp1;
SH3GL1
SH3-domain GRB2-like 1
SH3GL1; SH3-domain GRB2-like 1; endophilin-A2; CNSA1; EEN; extra 11 19 leukemia fusion; fusion partner of MLL; MGC111371; SH3 domain GRB2 like 1; SH3 containing Grb 2 like 1 protein; SH3 containing protein EEN; SH3D2B; SH3P8; EEN fusion partner of MLL; Endophilin-2; Extra 11 19 leukemia fusion gene; Extra eleven-nineteen leukemia fusion gene protein; SH3 domain protein 2B; SH3 domain-containing GRB2-like protein 1; SH3G1_HUMAN; extra 11-19 leukemia fusion; SH3-containing Grb-2-like 1 protein;
IGF2BP2
Insulin-like growth factor 2 mRNA binding protein 2
RP23-50H13.1; C330012H03Rik; IMP-2; Imp2; Neilsen; IGF-II mRNA-binding protein 2; IGF2 mRNA-binding protein 2; VICKZ family member 2; insulin-like growth factor 2 mRNA-binding protein 2; insulin-like growth factor 2, binding protein 2;
GADD45GIP1
growth arrest and DNA-damage-inducible, gamma interacting protein 1
GADD45GIP1; growth arrest and DNA-damage-inducible, gamma interacting protein 1; growth arrest and DNA damage-inducible proteins-interacting protein 1; CKBBP2; CKII beta binding protein 2; CR6 interacting factor 1; CRIF1; MGC4667; MGC4758; p53 responsive gene 6; papillomavirus L2 interacting nuclear protein 1; PLINP 1; Plinp1; PRG6; CKII beta associating protein; CKII beta-associating protein; CR6-interacting factor 1; G45IP_HUMAN; growth arrest and DNA damage inducible, gamma interacting protein 1; p53 responsive gene 6 protein; p53-responsive gene 6 protein; Papillomavirus L2-interacting nuclear protein 1; PLINP-1;
GNLY
granulysin
GNLY; granulysin; LAG2; D2S69E; LAG 2; NKG5; T lymphocyte activation gene 519; TLA519; lymphokine LAG-2; lymphocyte-activation gene 2; T-cell activation protein 519; T-lymphocyte activation gene 519; 519; LAG-2;
groL
Cpn60 Chaperonin GroEL, Large Subunit of GroESL
groL; Cpn60 chaperonin GroEL, large subunit of GroESL; CPN60, GROEL, HSP60, HSP65, SPG13, CHA60, GROL, crpA, mopA, 60 kDa chaperonin, Protein Cpn60, groEL protein, b4143, JW4103;
ILKAP
integrin-linked kinase-associated serine/threonine phosphatase
ILKAP; integrin-linked kinase-associated serine/threonine phosphatase; integrin linked kinase associated serine/threonine phosphatase 2C; integrin-linked kinase-associated serine/threonine phosphatase 2C; DKFZP434J2031; FLJ10181; protein phosphatase 2c, d;
ITGA8
integrin, alpha 8
ITGA8; integrin, alpha 8; integrin alpha-8; Integrin alpha 8; ITGA 8; OTTHUMP00000019207;
ABO
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
ABO; ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase); histo-blood group ABO system transferase; A3GALNT; A3GALT1; ABO glycosyltransferase; histo-blood group A transferase; histo-;
AAMP
angio-associated, migratory cell protein
AAMP; angio-associated, migratory cell protein; angio-associated migratory cell protein;
AGR3
anterior gradient 3 homolog
AGR3; anterior gradient 3 homolog (Xenopus laevis); anterior gradient protein 3 homolog; BCMP11; breast cancer membrane protein 11; hAG 3; HAG3; PDIA18; protein disulfide isomerase family A; member 18; AG-3; anterior gradient homolog 3; protein disulfide;
C4A
complement component 4A (Rodgers blood group)
C4A; complement component 4A (Rodgers blood group); C4; RG; C4S; CO4; C4A2; C4A3; C4A4; C4A6; C4AD; CPAMD2; complement C4-A; acidic C4; C4A anaphylatoxin; Rodgers form of C4; acidic complement C4; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2;
CD151
CD151 molecule (Raph blood group)
CD151; CD151 molecule (Raph blood group); CD151 antigen , CD151 antigen (Raph blood group); CD151 antigen; PETA 3; RAPH; SFA 1; TSPAN24; tspan-24; tetraspanin-24; membrane glycoprotein SFA-1; CD151 antigen (Raph blood group); hemidesmosomal tetraspanin CD151; platelet surface glycoprotein gp27; platelet-endothelial tetraspan antigen 3; platelet-endothelial cell tetraspan antigen 3; GP27; MER2; SFA1; PETA-3;
EDEM1
ER degradation enhancer, mannosidase alpha-like 1
EDEM1; ER degradation enhancer, mannosidase alpha-like 1; ER degradation-enhancing alpha-mannosidase-like 1; EDEM; KIAA0212; OTTHUMP00000206910; OTTHUMP00000206911;
EN1
engrailed homeobox 1
EN1; engrailed homeobox 1; homeobox protein engrailed-1; hu-En-1; engrailed homolog 1; homeobox protein en-1;
EN2
engrailed homeobox 2
EN2; engrailed homeobox 2; homeobox protein engrailed-2; AUTS 1; AUTS1; EN 2; Engrailed 2; Engrailed homeo box 2; Engrailed homolog 2; Engrailed2; Homeobox protein engrailed 2; Homeobox protein engrailed2; Hu En 2; HuEn2; MabEn; hu-En-2; engrailed-2; OTTHUMP00000199895; homeobox protein en-2;
EPM2A
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
EPM2A; epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); epilepsy, progressive myoclonus type 2, Lafora disease (laforin); laforin; LD; LDE; LAFPTPase; lafora PTPase; EPM2; MELF;
ERCC2
excision repair cross-complementing rodent repair deficiency, complementation group 2
ERCC2; excision repair cross-complementing rodent repair deficiency, complementation group 2; xeroderma pigmentosum complementary group D , XPD; TFIIH basal transcription factor complex helicase XPD subunit; EM9; excision repair cross complementing rodent;
ERVWE1
endogenous retrovirus group W, member 1
endogenous retroviral family W, env(C7), member 1; envelope glycoprotein; HERVW; envelope protein; HERV-7q; enverin; HERV-W-ENV; HERV-tryptophan envelope protein; Envelope polyprotein gPr73; HERV-W Env glycoprotein; HERV-7q Envelope protein; HERV-W_7q21.2 provirus ancestral Env polyprotein; HERV-W envelope protein; HERV-W{7q21.1} provirus ancestral Env polyprotein; HERV-W; human endogenous retrovirus W envC7-1 envelope protein; ENV; syncytin A; ENVW; syncytin-1; HERV7Q; Env-W; HERVWENV; OTTHUMP00000161914; Syncytin; ERVWE1; endogenous retrovirus group W member 1;
FANCA
Fanconi anemia, complementation group A
FANCA; Fanconi anemia, complementation group A; FACA, FANCH; Fanconi anemia group A protein; FA H; FAA; FAH; Fanconi anemia, type 1; Fanconi anemia, complementation group H; FA; FA1; FA-H; FACA; FANCH; MGC75158;
FANCB
Fanconi anemia, complementation group B
FANCB; Fanconi anemia, complementation group B; Fanconi anemia group B protein; FAAP95; FAB; FLJ34064; Fanconi anemia-associated polypeptide of 95 kDa; FA2; FACB; FAAP90;
FANCD2
Fanconi anemia, complementation group D2
FANCD2; Fanconi anemia, complementation group D2; FA4; FAD; FACD; FAD2; FA-D2; FANCD; Fanconi anemia group D2 protein;
FANCF
Fanconi anemia, complementation group F
FANCF; Fanconi anemia, complementation group F; FAF; Fanconi anemia group F protein;
FDPS
cross-linked fibrin degradation products
FDPs; Fibrin Degradation Products; Geranyltranstransferase; (2E; 6E)-farnesyl diphosphate synthase; dimethylallyltranstransferase; Farnesyl diphosphate synthase; Farnesyl diphosphate synthetase; Farnesyl pyrophosphate synthase; Farnesyl pyrophosphate synthetase; Fdps; FPP synthase; FPP synthetase; FPPS; FPS;
FUT1
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
FUT1; fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group); fucosyltransferase 1 (galactoside 2 alpha L fucosyltransferase) , fucosyltransferase 1 (galactoside 2 alpha L fucosyltransferase, Bombay phenotype included) , H, HSC; g;
GPRC5D
G protein-coupled receptor, family C, group 5, member D
GPRC5D; G protein-coupled receptor, family C, group 5, member D; G-protein coupled receptor family C group 5 member D; orphan G-protein coupled receptor; MGC129713; MGC129714;
GRB7
growth factor receptor-bound protein 7
GRB7; growth factor receptor-bound protein 7; B47; Epidermal growth factor receptor GRB 7; Epidermal growth factor receptor GRB-7; GRB7 adapter protein; GRB7_HUMAN; Growth factor receptor bound protein 7; OTTHUMP00000164349; OTTHUMP00000164350; OTTHUMP00000164351; OTTHUMP00000164352;
GREM1
Grem1 gremlin 1
GREM1; gremlin 1; gremlin-1; down-regulated in v-mos-transformed cells; cysteine knot superfamily 1, BMP antagonist 1; down-regulated in Mos-transformed cells protein; ld; Drm; Grem; Cktsf1b1;
GRM1
Grm1 glutamate receptor, metabotropic 1
GRM1; glutamate receptor, metabotropic 1; metabotropic glutamate receptor 1; G protein coupled receptor, family C, group 1, member A; G protein-coupled receptor, family C, group 1, member A; rcw; wobl; Gprc1a; mGluR1; nmf373; Gm10828; 4930455H15Rik; MGC90744; ENSMUSG00000075319;
GYPA
glycophorin A (MNS blood group)
Glycophorin A + B; GYPA; glycophorin A (MNS blood group); glycophorin A (includes MN blood group) , glycophorin A (MN blood group) , MNS; glycophorin-A; CD235a; GPA; MN; glycophorin MiI; glycophorin MiV; glycophorin SAT; glycophorin Erik; glycophorin A, GPA; MN sialoglycop;
GYPC
glycophorin C (Gerbich blood group)
GYPC; glycophorin C (Gerbich blood group); glycophorin-C; CD236; CD236R; Ge; GPC; GYPD; GLPC; GLPC_HUMAN; Glycoconnectin; Glycophorin D; Glycophorin-D; Glycoprotein beta; GPD; MGC117309; MGC126191; MGC126192; PAS 2; PAS-2; Sialoglycoprotein D; OTTHUMP00000162176; OTTHUMP00000203779;
GZMA
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
GZMA; granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3); HFSP; CTLA3; granzyme A; HF; h factor; CTL tryptase; fragmentin-1; cytotoxic T-lymphocyte proteinase 1; Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease);
HMG20A
high mobility group 20A
HMG20A; high mobility group 20A; high mobility group protein 20A; FLJ10739; HMG box domain containing 1; HMGX1; HMGXB1; high-mobility group 20A; HMG box-containing protein 20A; HMG domain-containing protein 1; HMG domain-containing protein HMGX1;
HMG20B
high mobility group 20B
HMG20B; high mobility group 20B; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related; BRAF25; BRAF35; HMG box domain containing 2; HMGX2; HMGXB2; SMARCE1r; SOXL; SMARCE1-related protein; high-mobility grou;
HMGN3
high mobility group nucleosomal binding domain 3
HMGN3; high mobility group nucleosomal binding domain 3; thyroid hormone receptor interactor 7 , TRIP7; high mobility group nucleosome-binding domain-containing protein 3; DKFZp686E20226; FLJ42187; HMGN3_HUMAN; OTTHUMP00000016772; OTTHUMP00000016773; PNAS 24; PNAS 25; PNAS24; PNAS25; Thyroid hormone receptor interacting protein 7; Thyroid receptor-interacting protein 7; TR-interacting protein 7; TRIP 7; TRIP-7; TRIP7; PNAS-24; PNAS-25;
IGF2BP3
insulin-like growth factor 2 mRNA binding protein 3
IGF2BP3; insulin-like growth factor 2 mRNA binding protein 3; insulin-like growth factor 2 mRNA-binding protein 3; cancer/testis antigen 98; CT98; IGF II mRNA binding protein 3; IMP 3; hKOC; VICKZ family member 3; IGF2 mRNA-binding protein 3; IGF-II mRNA-binding protein 3; KH domain containing protein overexpressed in cancer; KH domain-containing protein overexpressed in cancer; IMP3; KOC1; IMP-3; VICKZ3; DKFZp686F1078; OTTHUMP00000158561; VICKZ3.;
ING2
inhibitor of growth family, member 2
ING2; inhibitor of growth family, member 2; ING1L, inhibitor of growth family, member 1 like; inhibitor of growth protein 2; p33ING2; p32; ING1Lp; inhibitor of growth 1-like protein; ING1L;
ITGA1
integrin, alpha 1
ITGA1; integrin, alpha 1; integrin alpha-1; CD49a; VLA1; VLA-1; laminin and collagen receptor; very late activation protein 1; CD49 antigen-like family member A;
ITGA3
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); antigen identified by monoclonal J143 , MSK18; integrin alpha-3; CD49c; GAP B3; VCA 2; VLA3a; FRP-2; galactoprotein B3; VLA-3 subunit alpha; CD49 antigen-like family member C; antigen identified by monoclonal J143; very late activation protein 3 receptor, alpha-3 subunit; VL3A; GAPB3; MSK18; VCA-2; GAP-B3; FLJ34631; FLJ34704;
ITGAV
integrin, alpha V
ITGAV; integrin, alpha V; antigen identified by monoclonal L230 , integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) , MSK8, vitronectin receptor , VNRA, VTNR; integrin alpha-V; CD51; integrin alphaVbeta3; vitronectin receptor s;
ITGB1BP1
integrin beta 1 binding protein 1
ITGB1BP1; integrin beta 1 binding protein 1; integrin beta-1-binding protein 1; bodenin; ICAP 1A; ICAP 1alpha; ICAP 1B; ICAP1; ICAP1A; ICAP1B; integrin cytoplasmic domain associated protein 1; integrin cytoplasmic domain associated protein 1 alpha; integrin cytoplasmic domain associated protein 1 beta; DKFZp686K08158; ICAP 1; ICAP-1; Integrin cytoplasmic domain-associated protein 1; ITBP1_HUMAN; OTTHUMP00000115481; OTTHUMP00000115482; OTTHUMP00000195584; OTTHUMP00000195586; OTTHUMP00000214081; OTTHUMP00000214082; OTTHUMP00000214088; integrin cytoplasmic dom; ICAP-1A; ICAP-1B; ICAP-1alpha;
ITGB4
integrin, beta 4
ITGB4; integrin, beta 4; integrin beta-4; CD104; GP150; CD104 antigen; integrin beta-4 subunit;
ITGB6
Integrin, Beta 6
ITGB6; integrin, beta 6; OTTHUMP000001628962; OTTHUMP00000205127; OTTHUMP00000205128; OTTHUMP000002073332;
KEL
Kell blood group
KEL; Kell blood group; kell blood group glycoprotein homolog; CD238; CD238 antigen; ECE3; Kell blood group glycoprotein; Kell blood group metallo endopeptidase; Kell blood group metalloendopeptidase; KELL NULL; Kell protein; KELL_HUMAN; OTTMUSP00000032452; Kel blood group protein; Kell blood group, metallo-endopeptidase;
LOC124220
ZG16B zymogen granule protein 16 homolog B (rat)
PAUF; JCLN2; HRPE773; PRO1567; zymogen granule protein 16 homolog B; OTTHUMP00000159184; jacalin-like lectin domain containing 2; pancreatic adenocarcinoma upregulated factor;
NAB2
NGFI-A binding protein 2 (EGR1 binding protein 2)
NAB2; NGFI-A binding protein 2 (EGR1 binding protein 2); NGFI-A-binding protein 2; MADER; EGR1 binding protein 2; EGR-1-binding protein 2; melanoma-associated delayed early response protein; MGC75085;
NR0B1
nuclear receptor subfamily 0, group B, member 1
NR0B1; nuclear receptor subfamily 0, group B, member 1; AHC, dosage sensitive sex reversal , DSS; nuclear receptor subfamily 0 group B member 1; AHCH; DAX1; nuclear receptor DAX1; nuclear receptor DAX-1; nuclear hormone receptor; DSS-AHC critical region;
NR0B2
nuclear receptor subfamily 0, group B, member 2
NR0B2; nuclear receptor subfamily 0, group B, member 2; nuclear receptor subfamily 0 group B member 2; SHP; nuclear receptor SHP; small heterodimer partner; orphan nuclear receptor SHP; SHP1; FLJ17090;
NR2F1
NR2F1 nuclear receptor subfamily 2, group F, member 1
NR2F1; nuclear receptor subfamily 2, group F, member 1; ERBAL3, TFCOUP1; COUP transcription factor 1; COUP TFI; EAR 3; SVP44; TCFCOUP1; COUP-TF1; COUP-TF I; V-erbA-related protein 3; COUP transcription factor I; chicken ovalbumin upstream promoter-transcription factor I; transcription factor COUP 1 (chicken ovalbumin upstream promoter 1, v-erb-a homolog-like 3); EAR3; EAR-3; NR2F2; ERBAL3; TFCOUP1; COUP-TFI;
NR3C2
nuclear receptor subfamily 3, group C, member 2
NR3C2; nuclear receptor subfamily 3, group C, member 2; MR; MCR; MLR; NR3C2VIT; mineralocorticoid receptor; aldosterone receptor; mineralocorticoid receptor 1; mineralocorticoid receptor delta;
PCGF3
polycomb group ring finger 3
PCGF3; polycomb group ring finger 3; ring finger protein 3 , RNF3; polycomb group RING finger protein 3; DONG1; FLJ36550; MGC40413; RNF3A; ring finger protein 3; RING finger protein 3A; RNF3; FLJ43813; MGC129615; DKFZp686D20235;
PCGF5
polycomb group ring finger 5
PCGF5; polycomb group ring finger 5; ring finger protein (C3HC4 type) 159 , RNF159; polycomb group RING finger protein 5; MGC16202; RING finger protein 159; ring finger protein (C3HC4 type) 159; RNF159;
PCGF6
polycomb group ring finger 6
PCGF6; polycomb group ring finger 6; MBLR; RNF134; polycomb group RING finger protein 6; ring finger protein 134; Mel18 and Bmi1-like RING finger protein;
PDCD10
programmed cell death 10
PDCD10; programmed cell death 10; CCM3, cerebral cavernous malformations 3; programmed cell death protein 10; TFAR15; apoptosis-related protein 15; TF-1 cell apoptosis-related protein 15; cerebral cavernous malformations 3 protein; CCM3; MGC1212; MGC2447;
SCG2
secretogranin II
SCG2; secretogranin II; SN; CHGC; SgII; secretogranin-2; EM66; secretoneurin; chromogranin-C; OTTHUMP00000164218;
SDHD
succinate dehydrogenase complex, subunit D, integral membrane protein
SDHD; succinate dehydrogenase complex, subunit D, integral membrane protein; PGL, PGL1; succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial; QPs3; cybS; CII-4; succinate-ubiquinone reductase membrane anchor subunit; succinate-ubiquinone oxidoreductase cytochrome b small subunit; PGL; CBT1; PGL1; SDH4;
SLC25A16
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16
SLC25A16; solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16; graves disease carrier protein; D10S105E; GDA; HGT.1; ML7; graves disease autoantigen; solute carrier family 25 member 16; mitochondrial solute carrier prot;
XPA
xeroderma pigmentosum, complementation group A
XPA; xeroderma pigmentosum, complementation group A; DNA repair protein complementing XP-A cells; XP1; XPAC; excision repair-controlling; xeroderma pigmentosum group A-complementing protein;
Tox
thymocyte selection-associated high mobility group box
TOX; thymocyte selection-associated high mobility group box; thymocyte selection-associated high mobility group box protein TOX; KIAA0808; TOX1; Thymus high mobility group box protein TOX; TOX 1;
CGRRF1
cell growth regulator with ring finger domain 1
CGRRF1; cell growth regulator with ring finger domain 1; cell growth regulator with RING finger domain protein 1; CGR19; RNF197; Cell growth regulatory gene 19 protein; Cell Growth Regulatory with Ring Finger Domain; CGRRF 1; RING finger protein 197;
ITGB1BP2
integrin beta 1 binding protein (melusin) 2
ITGB1BP2; integrin beta 1 binding protein (melusin) 2; integrin beta-1-binding protein 2; CHORDC3; integrin beta 1 binding protein 2; ITGB1BP; MELUSIN; MGC119214; MSTP015;
OSGIN2
oxidative stress induced growth inhibitor family member 2
OSGIN2; oxidative stress induced growth inhibitor family member 2; C8orf1, chromosome 8 open reading frame 1; oxidative stress-induced growth inhibitor 2; hT41; C230027H09Rik; BC010311; C8orf1; MGC11786; OSGIN 2; OTTMUSP00000004957; RGD1306323; RP23-386N10.2;
AHI1
Abelson helper integration site 1
AHI1; Abelson helper integration site 1; jouberin; Abelson helper integration site 1 protein homolog; Abelson helper integration site; AHI 1; AHI-1; AHI1_HUMAN; Contatins SH3 and WD40 domains; dJ71N10.1; DKFZp686J1653; FLJ14023; FLJ20069; JBTS3; ORF1; OTTHUMP00000017263; OTTHUMP00000017265; OTTHUMP00000234456; OTTHUMP00000234654; OTTHUMP00000234656; abelson helper integration site 1 protein; D10Bwg0629e; 1700015F03Rik;
ERCC5
excision repair cross-complementing rodent repair deficiency, complementation group 5
ERCC5; excision repair cross-complementing rodent repair deficiency, complementation group 5; ERCM2, xeroderma pigmentosum, complementation group G , XPGC; DNA repair protein complementing XP-G cells; Cockayne syndrome; COFS 3; COFS3; DNA excision repair protein ERCC 5; DNA excision repair protein ERCC5; DNA repair protein complementing XP G cells; DNA repair protein complementing XPG cells; ERCC 5; ERCM 2; ERCM2; Excision Repair Cross Complementing Rodent Repair Deficiency; Excision repair cross complementing rodent repair deficiency complementation group 5; Excision repair protein; OTTHUMP00000064902; UVDR; Xeroderma Pigmentosum Complementation Group G; Xeroderma pigmentosum complementation group G protein; Xeroderma pigmentosum group G complementing protein; XPG; XPG complementing protein; XPGC; OTTHUMP00000018678; XPG-complementing protein; DNA excision repair protein ERCC-5; xeroderma pigmentosum, complementation group G;
FANCE
Fanconi anemia, complementation group E
FANCE; Fanconi anemia, complementation group E; FACE; Fanconi anemia group E protein; FAE; 2810451D06Rik; AI415634; AW209126; FANCE_HUMAN; Fanconi anemia complementation group E; Protein FACE; RGD1561045; OTTHUMP00000016254;
FCGR3
FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); Fc fragment of IgG, low affinity IIIa, receptor for (CD16) , FCG3, FCGR3; low affinity immunoglobulin gamma Fc region receptor III-A; CD16; CD16a; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; igG Fc receptor III-2; Fc gamma receptor III-A; Fc-gamma receptor IIIb (CD16); neutrophil-specific antigen NA; Fc-gamma receptor III-2 (CD 16); immunoglobulin G Fc receptor III; Fc fragment of IgG, low affinity III, receptor for (CD16); FCG3; CD16A; FCGR3; IGFR3; FCR-10; FCRIII; FCGRIII; FCRIIIA;
FGF11
fibroblast growth factor 11
FGF11; fibroblast growth factor 11; FHF3; fibroblast growth factor homologous factor 3; FLJ16061; MGC45269; MGC102953; FGF 11; FGF-11; FGF11_HUMAN; FHF 3; FHF-3; OTTHUMP00000135275;
FGF3
fibroblast growth factor 3
FGF3; fibroblast growth factor 3; fibroblast growth factor 3 (murine mammary tumor virus integration site (v int 2) oncogene homolog) , INT2; HBGF 3; INT 2 proto oncogene protein; murine mammary tumor virus integration site 2; mouse; oncogene INT2; V INT2;
FGFBP1
fibroblast growth factor binding protein 1
FGFBP1; fibroblast growth factor binding protein 1; fibroblast growth factor-binding protein 1; FGFBP; HBP17; 17 kDa heparin binding growth factor binding protein; FGF binding protein 1; FGF BP; FGF BP1; Fibroblast growth factor binding protein 1 precursor; FGF-binding protein 1; 17 kDa HBGF-binding protein; heparin-binding growth factor binding protein; 17 kDa heparin-binding growth factor-binding protein; FGF-BP; FGF-BP1; FGFBP-1;
FUT3
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
FUT3; fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group); fucosyltransferase 3 (galactoside 3(4) L fucosyltransferase, Lewis blood group included) , LE; galactoside 3(4)-L-fucosyltransferase; CD174; MGC131739; alpha (1,3/1,4) fucosyltransferase; Blood group Lewis alpha-4-fucosyltransferase; FT3B; Fucosyltransferase 3; Fucosyltransferase III; FucT-III; FUT3_HUMAN; galactoside 3(4) L fucosyltransferase, Lewis blood group; LE; Les; Lewis B Blood Group antigen; Lewis FT; alpha-(1,3/1,4)-fucosyltransferase;
GRIN2C
Grin2c glutamate receptor, ionotropic, NMDA2C (epsilon 3)
GRIN2C; glutamate receptor, ionotropic, NMDA2C (epsilon 3); glutamate [NMDA] receptor subunit epsilon-3; GluRepsilon3; N-methyl D-aspartate receptor subtype 2C; NR2C; NMDAR2C;
LTBP1
latent transforming growth factor beta binding protein 1
LTBP1; latent transforming growth factor beta binding protein 1; latent-transforming growth factor beta-binding protein 1; LTBP-1; TGF-beta1-BP-1; transforming growth factor beta-1-binding protein 1;
MIEN1
migration and invasion enhancer 1
chromosome 17 open reading frame 37; HBV XAg-transactivated protein 4; XTP4; RDX12; MGC14832; C35; ORB3; HBV X-transactivated gene 4 protein; Protein C35; protein C17orf37; OTTHUMP00000164348;
NR2C1
NR2C1 nuclear receptor subfamily 2, group C, member 1
NR2C1; nuclear receptor subfamily 2, group C, member 1; TR2; nuclear receptor subfamily 2 group C member 1; TR2 11; orphan nuclear receptor TR2; TR2 nuclear hormone receptor; nuclear receptor subfamily 2, group C isoform;
NR6A1
nuclear receptor subfamily 6, group A, member 1
NR6A1; nuclear receptor subfamily 6, group A, member 1; RTR; GCNF; NR61; hRTR; CT150; GCNF1; hGCNF; nuclear receptor subfamily 6 group A member 1; germ cell nuclear factor variant 1; retinoid receptor-related testis-specific receptor; retinoic acid receptor-related testis-associated receptor;
PLA2G4B
phospholipase A2, group IVB (cytosolic)
PLA2G4B; phospholipase A2, group IVB (cytosolic); cytosolic phospholipase A2 beta; cPLA2 beta; HsT16992; DKFZp686N12131; FLJ17693; FLJ42498; FLJ53173; OTTHUMP00000201605; OTTHUMP00000210673; Phospholipase A2 group IVB; cPLA2-beta;
PRG2
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
PRG2; proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein); MBP; BMPG; MBP1; bone marrow proteoglycan; bone-marrow proteoglycan; proteoglycan 2 preproprotein; natural killer cell activator; eosinophil major basic protein; eosinophil granule major basic protein; prg-2; Piwi (fruitfly) Related Gene; Piwi (fruitfly) Related Gene family member (prg-2); 4H292; tag-292;
RHCE
Rh blood group, CcEe antigens
Blood group RhCcEe antigen; CD240CE; CD240CE antigen; RH; Rh blood group antigen Evans; Rh blood group C antigen; Rh blood group, CcEe antigens; Rh polypeptide 1; Rh polypeptide I; RH30A; Rh4; RHC; RHCE blood group variant Crawford antigen Rh43; RHE; Rhesus blood group CE protein; Rhesus blood group E antigen; Rhesus blood group Rhce antigen; Rhesus blood group, CcEe antigens; Rhesus C/E antigens; Rhesus system C and E polypeptides; RhIVb(J); RHIXB; RHPI; RhVI; RhVIII;
SSNA1
Sjogren syndrome nuclear autoantigen 1
SSNA1; Sjogren syndrome nuclear autoantigen 1; Sjogrens syndrome nuclear autoantigen 1; Sjoegren syndrome nuclear autoantigen 1; N14; NA14; NA 14; Nuclear autoantigen of 14 kDa; SSNA 1; OTTHUMP00000022691; NA-14;
UFD1L
ubiquitin fusion degradation 1 like
UFD1L; ubiquitin fusion degradation 1 like (yeast); ubiquitin fusion degradation 1 like; ubiquitin fusion degradation protein 1 homolog; UFD1; UB fusion protein 1;
GRIA4
Gria4 glutamate receptor, ionotropic, AMPA4 (alpha 4)
GRIA4; glutamate receptor, ionotropic, AMPA4 (alpha 4); glutamate receptor 4; spike wave 1; glutamate receptor channel alpha 4; AMPA-selective glutamate receptor 4; glutamate receptor ionotropic, AMPA 4; GluA4; Glur4; spkw1; GluR-D; Glur-4; Gluralpha4;
ING4
inhibitor of growth family, member 4
ING4; inhibitor of growth family, member 4; inhibitor of growth protein 4; my036; p29ING4; brain my036 protein; candidate tumor suppressor p33 ING1 homolog; MGC12557;
SGIP1
SH3-domain GRB2-like (endophilin) interacting protein 1
SGIP1; SH3-domain GRB2-like (endophilin) interacting protein 1; SH3-containing GRB2-like protein 3-interacting protein 1; DKFZp761D221; endophilin-3-interacting protein; FLJ33378; FLJ43054; DKFZp686A16142;
NAB1
NGFI-A binding protein 1 (EGR1 binding protein 1)
NAB1; NGFI-A binding protein 1 (EGR1 binding protein 1); NGFI-A-binding protein 1; EGR1 binding protein 1; EGR-1-binding protein 1; transcriptional regulatory protein p54;
NR2F6
NR2F6 nuclear receptor subfamily 2, group F, member 6
NR2F6; nuclear receptor subfamily 2, group F, member 6; ERBAL2; nuclear receptor subfamily 2 group F member 6; EAR 2; ERBA-related gene-2; V-erbA-related protein 2; nuclear receptor V-erbA-related; v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 2; EAR2; EAR-2;
EGR2
early growth response 2
EGR2; early growth response 2; AT591; CMT1D; CMT4E; KROX20; E3 SUMO-protein ligase EGR2; zinc finger protein Krox-20; early growth response protein 2; KROX-20, Drosophila, homolog (early growth response-2);
DARC
Duffy blood group, chemokine receptor
DARC; Duffy blood group, chemokine receptor; Duffy blood group , FY; Duffy antigen/chemokine receptor; CCBP1; CD234; Dfy; GPD; glycoprotein D; Fy glycoprotein; Duffy blood group antigen; plasmodium vivax receptor; FY; GpFy; WBCQ1;
FGF13
fibroblast growth factor 13
FGF13; fibroblast growth factor 13; FGF2; FHF2; fibroblast growth factor homologous factor 2; FGF 13; FGF 2; FGF-13; FGF13_HUMAN; FHF 2; FHF-2; OTTHUMP00000024143; OTTHUMP00000024144;
GFER
growth factor, augmenter of liver regeneration
GFER; growth factor, augmenter of liver regeneration; ALR; HPO; HSS; ERV1; HPO1; HPO2; HERV1; FAD-linked sulfhydryl oxidase ALR; ERV1 homolog; hepatopoietin protein; erv1-like growth factor; hepatic regenerative stimulation substance;
GHRHR
growth hormone releasing hormone receptor
GHRHR; growth hormone releasing hormone receptor; growth hormone-releasing hormone receptor; GHRFR; GHRH R; GHRH receptor; GHRHR_HUMAN; GHRHRpsv; GRF R; GRF receptor; GRFR; Growth hormone releasing factor receptor; Growth hormone-releasing factor receptor; IGHD1B;
GHSR
growth hormone secretagogue receptor
GHSR; growth hormone secretagogue receptor; growth hormone secretagogue receptor type 1; GH releasing peptide receptor; GH-releasing peptide receptor; Ghrelin receptor; GHRP; GHRPR; GHS-R; GHSR_HUMAN; Growth hormone secretagogue receptor 1; growth hormone secretatgogue receptor;
GPRIN1
G protein regulated inducer of neurite outgrowth 1
GPRIN1; G protein regulated inducer of neurite outgrowth 1; G protein-regulated inducer of neurite outgrowth 1; GRIN1; KIAA1893;
ING5
inhibitor of growth family, member 5
ING5; inhibitor of growth family, member 5; inhibitor of growth protein 5; FLJ23842; p28ING5; 1700001C14Rik; 1700027H23Rik; 1810018M11Rik; ING 5; ING-5; Inhibitor of growth family member 5; p28 ING 5; p28 ING-5; p28 ING5;
NR5A1
nuclear receptor subfamily 5, group A, member 1
NR5A1; nuclear receptor subfamily 5, group A, member 1; ELP; SF1; FTZ1; POF7; SF-1; AD4BP; FTZF1; SPGF8; SRXY3; steroidogenic factor 1; STF-1; nuclear receptor AdBP4; steroidogenic factor-1; adrenal 4 binding protein; adrenal 4-binding protein; fushi tarazu factor homolog 1; steroid hormone receptor Ad4BP; steroidogenic factor 1 nuclear receptor;
OGFR
opioid growth factor receptor
OGFR; opioid growth factor receptor; 7 60; 7-60 protein; protein 7-60; zeta-type opioid receptor;
TBRG4
transforming growth factor beta regulator 4
TBRG4; transforming growth factor beta regulator 4; protein TBRG4; cell cycle progression 2 protein; Cpr2; FAST kinase domains 4; FASTKD4; H_TD2522F11.8; KIAA0948; Cell cycle progression protein 2; Cell cycle progression restoration protein 2; FAST kinase domain containing protein 4; FAST kinase domain-containing protein 4;
FLVCR2
feline leukemia virus subgroup C cellular receptor family, member 2
FLVCR2; feline leukemia virus subgroup C cellular receptor family, member 2; C14orf58, chromosome 14 open reading frame 58 , feline leukemia virus subgroup C cellular receptor 2; feline leukemia virus subgroup C receptor-related protein 2; FLJ20371; MFS;
GRAP
GRB2-related adaptor protein
GRAP; GRB2-related adaptor protein; GRB2-related adapter protein; GRB2 related adaptor protein; Growth factor receptor bound protein 2 related adaptor protein; MGC64880; OTTHUMP00000065766; growth factor receptor-bound protein 2-related adaptor protein;
Grasp
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein
GRASP; GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein; general receptor for phosphoinositides 1-associated scaffold protein; GRP1-associated scaffold protein; TAMALIN;
RPGRIP1L
RPGRIP1-like
RPGRIP1L; RPGRIP1-like; protein fantom; CORS3; fantom homolog; FTM; JBTS7; KIAA1005; Meckel syndrome; type 5; MKS5; NPHP8; nephrocystin 8; nephrocystin-8; RPGRIP1-like protein; RPGR-interacting protein 1-like protein; DKFZp686C0668;
Tox4
TOX high mobility group box family member 4
TOX4; TOX high mobility group box family member 4; C14orf92, chromosome 14 open reading frame 92 , KIAA0737; LCP1; migration-inducing protein 7; epidermal Langerhans cell protein LCP1; MIG7; C14orf92; KIAA0737;
WNT2B
wingless-type MMTV integration site family, member 2B
WNT2B; wingless-type MMTV integration site family, member 2B; WNT13; protein Wnt-2b; wingless type MMTV integration site family; member 13; XWNT2; Xenopus; homolog of; XWNT2, Xenopus, homolog of; wingless-type MMTV integration site family, member 13;
WNT4
wingless-related MMTV integration site 4
WNT4; wingless-related MMTV integration site 4; protein Wnt-4; signal molecule; Wnt-4; MGC123964; SERKAL;
ADAM21
a disintegrin and metallopeptidase domain 21
ADAM21; a disintegrin and metallopeptidase domain 21; Adam31; disintegrin and metalloproteinase domain-containing protein 21; ADAM 21; ADAM 31; a disintegrin and metalloprotease domain 21; a disintegrin and metalloprotease domain (ADAM) 21; disintegrin and metalloproteinase domain-containing protein 31;
ART4
ADP-ribosyltransferase 4 (Dombrock blood group)
ART4; ADP-ribosyltransferase 4 (Dombrock blood group); ADP ribosyltransferase 4 , ADP ribosyltransferase 4 (DO blood group) , DO, Dombrock blood group; ecto-ADP-ribosyltransferase 4; CD297; DOK1; ADP ribosyltransferase 4 (DO blood group); ADP ribosyltransferase 4 (Dombrock blood group); ADP ribosyltransferase 4; ART 4; CD297 antigen; DO; Dombrock blood group carrier molecule; Ecto ADP ribosyltransferase 4; Mono ADP ribosyltransferase 4; Mono(ADP ribosyl)transferase 4; NAD(P)(+) arginine ADP ribosyltransferase 4; mono-ADP-ribosyltransferase 4; mono(ADP-ribosyl)transferase 4; ADP-ribosyltransferase 4 (DO blood group); NAD(P)(+)--arginine ADP-ribosyltransferase 4;
AQP3
Aquaporin 3 (Gill Blood Group)
AQP3; aquaporin 3 (Gill blood group); GIL; AQP-3; aquaporin-3; aquaglyceroporin-3; aquaporin 3 (GIL blood group); aquaporin 3; OTTHUMP00000021206; Gill blood group;
IGFALS
insulin-like growth factor binding protein, acid labile subunit
IGFALS; insulin-like growth factor binding protein, acid labile subunit; insulin-like growth factor-binding protein complex acid labile subunit; ALS; insulin-like growth factor binding protein complex acid labile chain;
ANKH
ankylosis, progressive homolog (mouse)
ANKH; ankylosis, progressive homolog (mouse); ankylosis, progressive (mouse) homolog , CCAL2, CMDJ, craniometaphyseal dysplasia, Jackson type (dominant); progressive ankylosis protein homolog; ANK; CPPDD; HANK; Ankylosis progressive homolog (mouse); Ankylosis progressive homolog; CCAL 2; CCAL2; CMDJ; Craniometaphyseal dysplasia Jackson type (dominant); FLJ27166; MANK; OTTHUMP00000115641;
ASCC1
activating signal cointegrator 1 complex subunit 1
ASCC1; activating signal cointegrator 1 complex subunit 1; ASC1p50; CGI 18; Em:AC022392.3; ASC-1 complex subunit p50; ASC1 complex subunit p50; ASCC1_HUMAN; RP11-150D20.4; Trip4 complex subunit p50; p50; CGI-18;
B3GALNT1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
B3GALNT1; beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group); B3GALT3, UDP Gal:betaGlcNAc beta 1,3 galactosyltransferase, polypeptide 3 (Globoside blood group) , UDP GalNAc:betaGlcNAc beta 1,3 galactosaminyltransferase, polypeptide 1 (;
BIN2
bridging integrator 2
BIN2; bridging integrator 2; BRAP 1; BIN2_HUMAN; Breast cancer associated protein BRAP1; Breast cancer-associated protein 1; bridging integrator-2; BRAP-1;
CLN8
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
CLN8; ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation); C8orf61, chromosome 8 open reading frame 61 , EPMR; protein CLN8; FLJ39417; EPMR; C8orf61;
TOX2
TOX high mobility group box family member 2
TOX2; TOX high mobility group box family member 2; C20orf100, chromosome 20 open reading frame 100; dJ1108D11.2; GCX 1; granulosa cell HMG box 1; Chromosome 20 open reading frame 100; dJ495O3.1; GCX1; Granulosa cell HMG box protein 1; MGC15880; Weakly similar to NONHISTONE CHROMOSOMAL PROTEIN 6A [S.cerevisiae]; OTTHUMP00000031037; OTTHUMP00000031038; GCX-1; C20orf100;
PLA2G6
phospholipase A2, group VI (cytosolic, calcium-independent)
PLA2G6; phospholipase A2, group VI (cytosolic, calcium-independent); 85 kDa calcium-independent phospholipase A2; iPLA2; PARK14; PNPLA9; 85 kDa calcium independent phospholipase A2; CaI PLA2; CaI-PLA2; CaIPLA2; Calcium independent phospholipase A2; Cytosolic calcium independent phospholipase A2; EC 3.1.1.4; Group VI phospholipase A2; GVI; GVI PLA2; INAD1; iPLA(2)beta; IPLA2 VIA; iPLA2beta; NBIA2A; NBIA2B; PA2G6_HUMAN; Patatin like phospholipase domain containing 9; Patatin like phospholipase domain containing protein 9; Phospholipase A2 calcium independent; Phospholipase A2 calcium independent group VI A; Phospholipase A2 group VI; Phospholipase A2 group VI cytosolic calcium independent; PLA2; calcium-independent phospholipase A2; patatin-like phospholipase domain containing 9; cytosolic, calcium-independent phospholipase A2; IPLA2-VIA;
CIB3
calcium and integrin binding family member 3
CIB3; calcium and integrin binding family member 3; calcium and integrin-binding family member 3; KIP3; KIP 3; kinase-interacting protein 3; DNA-dependent protein kinase catalytic subunit-interacting protein 3; MGC96922; MGC138405; MGC142151;
ITFG1
integrin alpha FG-GAP repeat containing 1
ITFG1; integrin alpha FG-GAP repeat containing 1; T-cell immunomodulatory protein; CDA08; T cell immunomodulatory protein; TIP; Integrin alpha FG GAP repeat containing protein 1; TIP1; 2310047C21Rik; integrin-alpha FG-GAP repeat-containing protein 1;
EPS8
epidermal growth factor receptor pathway substrate 8
EPS8; epidermal growth factor receptor pathway substrate 8; epidermal growth factor receptor kinase substrate 8;
INTS8
integrator complex subunit 8
INTS8; integrator complex subunit 8; C8orf52, chromosome 8 open reading frame 52; FLJ20530; INT8; MGC131633; C8orf52; Chromosome 8 open reading frame 52; INTS 8; KAONASHI protein 1; KAONASHI1; protein kaonashi-1;
EPS15
epidermal growth factor receptor pathway substrate 15
EPS15; epidermal growth factor receptor pathway substrate 15; epidermal growth factor receptor substrate 15; AF 1P; MLLT5; protein AF-1p; ALL1 fused gene from chromosome 1; AF1P; AF-1P;
INTS7
integrator complex subunit 7
INTS7; integrator complex subunit 7; C1orf73, chromosome 1 open reading frame 73; DKFZP434B168; INT7; 5930412E23Rik; C1orf73; Chromosome 1 open reading frame 73; chunp6916; FLJ10736; FLJ12447; Ints7 integrator complex subunit 7; OTTHUMP00000035211; RGD1308014;
ERV3-1
endogenous retrovirus group 3, member 1
ERV3-1; endogenous retrovirus group 3, member 1; endogenous retroviral sequence 3 , endogenous retroviral sequence 3 (includes zinc finger protein H plk/HPF9) , ERV3; HERV-R_7q21.2 provirus ancestral Env polyprotein; envR; ERV R; H PLK; HERV R; ERVR; Endogenous retroviral sequence 3; Endogenous retrovirus group 3 member 1; ENR1_HUMAN; Envelope polyprotein; ERV-3 envelope protein; ERV-R envelope protein; ERV3 1 envelope protein; ERV3; ERV3 envelope protein; FLJ23884; HERV-R envelope protein; HERVR; SU; TM; Transmembrane protein; ERV3-1 envelope protein; ERV-R; HERV-R;
FANCI
Fanconi anemia, complementation group I
FANCI; Fanconi anemia, complementation group I; KIAA1794; Fanconi anemia group I protein; FLJ10719; FLJ14658; Protein FANCI;
FANCL
Fanconi anemia, complementation group L
FANCL; Fanconi anemia, complementation group L; PHD finger protein 9 , PHF9; E3 ubiquitin-protein ligase FANCL; FAAP43; FLJ10335; Pog; FANCL_HUMAN; Fanconi anemia complementation group L; Fanconi anemia group L protein; Fanconi anemia-associated polypeptide of 43 kDa; PHD finger protein 9; PHF9; Ubiquitin ligase protein FANCL;
FANCM
Fanconi anemia, complementation group M
FANCM; Fanconi anemia, complementation group M; FAAP250; KIAA1596; Fanconi anemia group M protein; protein Hef ortholog; ATP-dependent RNA helicase FANCM; fanconi anemia-associated polypeptide of 250 kDa;
EVI2A
ecotropic viral integration site 2A
EVI2A; ecotropic viral integration site 2A; EVI2; protein EVI2A; EVDA; Ecotropic viral integration site 2A protein homolog; EVI-2A;
EVI5
ecotropic viral integration site 5
EVI5; ecotropic viral integration site 5; NB4S; ecotropic viral integration site 5 protein homolog; EVI-5; neuroblastoma stage 4S gene protein; dJ846D11.1 (ecotropic viral integration site 5);
EVI5L
ecotropic viral integration site 5-like
EVI5L; ecotropic viral integration site 5-like; EVI5-like protein; Ecotropic viral integration site 5 like protein; EVI5 like protein; ecotropic viral integration site 5-like protein;
GCC1
GRIP and coiled-coil domain containing 1
GCC1; GRIP and coiled-coil domain containing 1; golgi coiled coil 1; GRIP and coiled-coil domain-containing protein 1; FLJ22035; GCC1P; GCC88; MGC20706; GCC protein; Golgi coiled coil protein 1; GRIP and coiled coil domain containing 1; Peripheral membrane Golgi protein; golgi coiled-coil 1; golgi coiled-coil protein 1;
GPRIN2
G protein regulated inducer of neurite outgrowth 2
GPRIN2; G protein regulated inducer of neurite outgrowth 2; KIAA0514; G protein-regulated inducer of neurite outgrowth 2; MGC15171; Gm286; C130040D06Rik; C230073P13; GRIN2; GRIN2_HUMAN; mKIAA0514; RGD1308922;
GAS2L1
growth arrest-specific 2 like 1
GAS2L1; growth arrest-specific 2 like 1; GAS2-like protein 1; GAR22; GA2L1_HUMAN; GAR 22; GAS2 like protein 1; GAS2 related protein on chromosome 22; GAS2-related protein on chromosome 22; Growth arrest specific 2 like 1; Growth arrest specific protein 2 like 1; Growth arrest-specific protein 2-like 1; MGC17243;
GAS8
growth arrest-specific 8
GAS8; growth arrest-specific 8; GAS11, growth arrest specific 11; growth arrest-specific protein 8; Growth arrest specific protein 8; MGC138326; GAS 11; GAS 8; GAS11; Growth arrest specific 11; Growth arrest specific 8; Growth arrest specific protein 11; GAS-8; GAS-11; growth arrest-specific 11; growth arrest-specific protein 11;
GPRC5B
G protein-coupled receptor, family C, group 5, member B
GPRC5B; G protein-coupled receptor, family C, group 5, member B; G protein coupled receptor, family C, group 1, member B; G-protein coupled receptor family C group 5 member B; RAIG 2; A-69G12.1; retinoic acid-induced gene 2 protein; retinoic acid responsi;
GFI1B
growth factor independent 1B transcription repressor
GFI1B; growth factor independent 1B transcription repressor; growth factor independent 1B (potential regulator of CDKN1A, translocated in CML); zinc finger protein Gfi-1b; growth factor independent protein 1B; potential regulator of CDKN1A translocated in;
GAS1
growth arrest-specific 1
GAS1; growth arrest-specific 1; growth arrest-specific protein 1; GAS-1; Growth arrest-specific gene-1;
FGF14
fibroblast growth factor 14
FGF14; fibroblast growth factor 14; FHF4; SCA27; MGC119129; MGC129319; bA397O8.2; FHF 4; Fibroblast growth factor homologous factor 4; mFHF-4(1B); MGC129318; RP11-397O8.6; FHF-4; FGF-14;
FGFBP2
fibroblast growth factor binding protein 2
FGFBP2; fibroblast growth factor binding protein 2; fibroblast growth factor-binding protein 2; killer specific secretory protein of 37 kDa; KSP37; FGF-BP2; FGFBP-2; HBp17-RP; FGF-binding protein 2; HBp17-related protein; 37 kDa killer-specific secretory;
GCNT2
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
GCNT2; glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group); cataract, congenital , CCAT, GCNT5, glucosaminyl (N acetyl) transferase 2, I branching enzyme , glucosaminyl (N acetyl) transferase 2, I branching enzyme (Ii blood group) , glucosaminyl (N acetyl) transferase 5 , II, NACGT1; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase; bA360O19.2; bA421M1.1; IGNT; Ii blood group; NAGCT1; ULG3; unassigned linkage group 3; Beta 1 6 N acetylglucosaminyltransferase 2; CCAT; GCNT 2; GCNT2C; GCNT5; Glucosaminyl (N acetyl) transferase 2 I branching enzyme (I blood group); Glucosaminyl (N acetyl) transferase 2 I branching enzyme; I beta 1 6 N acetylglucosaminyltransferase; I branching beta 1 6 acetylglucosaminyltransferase; I branching enzyme; II; MGC163396; N acetylglucosaminyltransferase; N acetyllactosaminide beta 1 6 N acetylglucosaminyltransferase; NACGT1; I-branching enzyme; OTTHUMP00000016015; OTTHUMP00000016018; OTTHUMP00000016021; N-acetylglucosaminyltransferase; I beta-1,6-N-acetylglucosaminyltransferase; beta-1,6-N-acetylglucosaminyltransferase 2; I-branching beta-1,6-acetylglucosaminyltransferase; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase;
GREB1
growth regulation
GREB1; growth regulation; protein GREB1; gene regulated in breast cancer 1 protein; gene regulated by estrogen in breast cancer;
GIN1
gypsy retrotransposon integrase 1
GIN1; gypsy retrotransposon integrase 1; ZH2C2, zinc finger, H2C2 domain containing; gypsy retrotransposon integrase-like protein 1; FLJ20125; GIN 1; gypsy integrase 1; TGIN1; Ty3/Gypsy integrase 1; zinc finger, H2C2 domain containing; zinc finger H2C2 d;
GRHL1
grainyhead-like 1 (Drosophila)
GRHL1; grainyhead-like 1 (Drosophila); MGR; NH32; LBP32; TFCP2L2; grainyhead-like protein 1 homolog; LBP protein 32; mammalian grainyhead; transcription factor LBP-32; transcription factor CP2-like 2;
GRAMD1A
GRAM domain containing 1A
GRAMD1A; GRAM domain containing 1A; KIAA1533; GRAM domain-containing protein 1A; FLJ90346; FLJ22411;
GRHL2
grainyhead-like 2 (Drosophila)
GRHL2; grainyhead-like 2 (Drosophila); deafness, autosomal dominant 28 , DFNA28, TFCP2L3, transcription factor CP2 like 3; grainyhead-like protein 2 homolog; BOM; FLJ13782; DFNA28; FLJ11172; MGC149294; TFCP2L3; Brother of mammalian grainyhead; Deafness autosomal dominant 28; Grainyhead like 2 (Drosophila); Grainyhead like 2; Grainyhead like protein 2 homolog; GRHL 2; MGC149295; Transcription factor CP2 like 3; transcription factor CP2-like 3;
HR
hair growth associated
HR; hair growth associated; AU; MUHH; ALUNC; MUHH1; HSA277165; protein hairless; hairless homolog;
HMGN4
high mobility group nucleosomal binding domain 4
HMGN4; high mobility group nucleosomal binding domain 4; high mobility group (nonhistone chromosomal) protein 17 like 3 , HMG17L3; high mobility group nucleosome-binding domain-containing protein 4; NHC; High mobility group (nonhistone chromosomal) protein 17 like 3; High mobility group protein 17 like 3; High mobility group protein N4; HMG17L3; HMGN4_HUMAN; MGC5145; Non-histone chromosomal protein; Non-histone chromosomal protein HMG-17-like 3; high-mobility group protein 17-like 3; high-mobility group (nonhistone chromosomal) protein 17-like 3;
GPRC6A
G protein-coupled receptor, family C, group 6, member A
GPRC6A; G protein-coupled receptor, family C, group 6, member A; G-protein coupled receptor family C group 6 member A; bA86F4.3; hGPCR33; hGPRC6A; predicted with SOSUI analysis; G-protein coupled receptor GPCR33; seven transmembrane helix receptor; GPCR;
GPRC5C
G protein-coupled receptor, family C, group 5, member C
GPRC5C; G protein-coupled receptor, family C, group 5, member C; G-protein coupled receptor family C group 5 member C; RAIG 3; orphan G-protein coupled receptor; retinoic acid-induced gene 3 protein; retinoic acid responsive gene protein; RAIG3; RAIG-3; M;
groES
co-chaperonin GroES
groES; co-chaperonin GroES; 10 kDa chaperonin; groES protein; groS; mopB; Protein Cpn10; Cpn10; forms homoheptameric ring; binds to one or both ends of the GroEL double barrel in the presence of adenine nucleotides capping it; folding of unfolded substrates initiates in a GroEL-substrate bound and capped by GroES; release of the folded substrate is dependent on ATP binding and hydrolysis in the trans ring;
GRPEL2
GrpE-like 2, mitochondrial (E. coli)
GRPEL2; GrpE-like 2, mitochondrial (E. coli); grpE protein homolog 2, mitochondrial; DKFZp451C205; FLJ23713; Mt GrpE#2; GrpE like 2, mitochondrial; GRPEL 2; Mt-GrpE#2;
GRTP1
growth hormone regulated TBC protein 1
GRTP1; growth hormone regulated TBC protein 1; growth hormone-regulated TBC protein 1; FLJ22474; TBC1D6; GRTP1_HUMAN; MGC138328; MGC138330; OTTHUMP00000018752; TBC1 domain family member 6; TBC1 domain family, member 6;
GYPB
glycophorin B (MNS blood group)
GYPB; glycophorin B (MNS blood group); glycophorin B (includes Ss blood group) , glycophorin B (Ss blood group) , MNS; glycophorin-B; CD235b; GPB; SS; GLPB_HUMAN; PAS-3; Sialoglycoprotein delta; SS-active sialoglycoprotein; Ss blood group; glycophorin HeP2; glycophorin MiVI; MNS; GPB.NY; HGpMiVI; GYPHe.NY;
HMGB4
high mobility group box 4
HMGB4; high mobility group box 4; high mobility group protein B4; FLJ40388; HMG2 like; dJ1007G16.5;
INTS3
integrator complex subunit 3
INTS3; integrator complex subunit 3; C1orf60, chromosome 1 open reading frame 60; FLJ21919; INT3; C1orf193; C1orf60; INT 3; SOSS complex subunit A; RP11-216N14.4; sensor of ssDNA A; OTTHUMP00000035161; OTTHUMP00000038687; OTTHUMP00000222672; sensor of ssDNA subunit A; sensor of single-strand DNA complex subunit A; SOSS-A; RP11-216N14.2;
INTS4
integrator complex subunit 4
INTS4; integrator complex subunit 4; INT4; MGC16733; MST093; MSTP093; RGD1305036; OTTHUMP00000233860;
ERVFRD-1
endogenous retrovirus group FRD, member 1
ERVFRD-1; endogenous retrovirus group FRD, member 1; HERV-FRD_6p24.1 provirus ancestral Env polyprotein; envFRD; ERVFRDE1; HERV FRD; HERV W/FRD; syncytin 2; envelope polyprotein; endogenous retrovirus group FRD member 1; HERV-FRD provirus ancestral Env po;
HDGFRP2
hepatoma-derived growth factor, related protein 2
HDGFRP2; hepatoma-derived growth factor, related protein 2; hepatoma-derived growth factor-related protein 2; HDGF-2; HDGR2_HUMAN; Hepatoma-derived growth factor 2; Hepatoma-derived growth factor; heptoma derived growth factor related protein 2; HRP-2;
INTS5
integrator complex subunit 5
INTS5; integrator complex subunit 5; KIAA1698; INT5; 1110055N21Rik; mKIAA1698; RGD1309370; OTTHUMP00000236323;
ICAM4
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
ICAM4; intercellular adhesion molecule 4 (Landsteiner-Wiener blood group); intercellular adhesion molecule 4 (LW blood group) , intercellular adhesion molecule 4, Landsteiner Wiener blood group , Landsteiner Wiener blood group , LW; intercellular adhesion molecule 4; CD242; CD242 antigen; ICAM-4; ICAM4_HUMAN; Landsteiner Wiener blood group glycoprotein; Landsteiner-Wiener blood group glycoprotein; LW; LW blood group protein; Landsteiner-Wiener blood group antigen a; intercellular adhesion molecule 4 (LW blood group);
INTS10
integrator complex subunit 10
INTS10; integrator complex subunit 10; C8orf35, chromosome 8 open reading frame 35; FLJ10569; INT10; C8orf35;
IGF2BP1
insulin-like growth factor 2 mRNA binding protein 1
IGF2BP1; insulin-like growth factor 2 mRNA binding protein 1; insulin-like growth factor 2 mRNA-binding protein 1; IGF II mRNA binding protein 1; IMP 1; ZBP-1; VICKZ family member 1; zipcode-binding protein 1; IGF2 mRNA-binding protein 1; IGF-II mRNA-bind;
ITGA11
integrin, alpha 11
ITGA11; integrin, alpha 11; integrin alpha-11; HsT18964; integrin a11; Integrin alpha 11; ITA11_HUMAN;
ITGB1BP3
integrin beta 1 binding protein 3
ITGB1BP3; integrin beta 1 binding protein 3; nicotinamide riboside kinase 2; MIBP; muscle specific beta 1 integrin binding protein; NRK2; 2310015C21Rik,; MGC126624; Muscle integrin binding protein; Nicotinic acid riboside kinase 2; NmR K 2; NRK 2; Ribosylnicotinamide kinase 2; Ribosylnicotinic acid kinase 2; RNK 2; nmR-K 2; muscle integrin-binding protein; integrin beta-1-binding protein 3; muscle-specific beta 1 integrin binding protein;
ITM2C
integral membrane protein 2C
ITM2C; integral membrane protein 2C; BRI3; E25; hRPC.1050_D_4; ITM3; E25C;
MORGUE
modifier of rpr and grim, ubiquitously expressed
MORGUE; modifier of rpr and grim, ubiquitously expressed; CG15437 gene product from transcript CG15437-RA; BcDNA.GH02435; CG15437-PA; F box/ubiquitin conjugase; modifier of rpr and grim ubiquitously expressed; morgue-PA; BcDNA:GH02435; CG15437; Dmel\CG15437;
MIIP
migration and invasion inhibitory protein
MIIP; migration and invasion inhibitory protein; migration and invasion-inhibitory protein; FLJ12438; IIp45; invasion inhibitory protein 45; FLJ38609; IGFBP 2 binding protein; IGFBP2 binding protein; RP5 1077B9.4; IGFBP2-binding protein; invasion-inhibitory protein 45; RP5-1077B9.4;
MRVI1
murine retrovirus integration site 1 homolog
MRVI1; murine retrovirus integration site 1 homolog; protein MRVI1; inositol 1; 4; 5 triphosphate associated cGMP kinase substrate; IP3R associated cGMP kinase substrate; IRAG; JAW1L; JAW1-related protein MRVI1; IP3R-associated cGMP kinase substrate; inos;
NR1H5
nuclear receptor subfamily 1, group H, member 5
NR1H5; nuclear receptor subfamily 1, group H, member 5; Fxrb;
HMGN5
high mobility group nucleosome binding domain 5
HMGN5; high mobility group nucleosome binding domain 5; high mobility group nucleosome binding domain 5 , NSBP1, nucleosomal binding protein 1; high mobility group nucleosome-binding domain-containing protein 5; NSBP 1; Nucleosomal binding protein 1; Nucleosome binding protein 1; nucleosome-binding protein 1; high-mobility group nucleosome binding domain 5; NSBP1; NBP-45;
ITGBL1
integrin, beta-like 1 (with EGF-like repeat domains)
ITGBL1; integrin, beta-like 1 (with EGF-like repeat domains); integrin beta-like protein 1; integrin beta like 1; OSCP; ten integrin EGF like repeat domains protein; TIED; osteoblast-specific cysteine-rich protein; ten integrin EGF-like repeat domains pro;
GPRC5A
G protein-coupled receptor, family C, group 5, member A
GPRC5A; G protein-coupled receptor, family C, group 5, member A; GPCR5A, RAI3, retinoic acid induced 3; retinoic acid-induced protein 3; RAIG1; RAIG-1; retinoic acid induced 3; retinoic acid responsive; retinoic acid-induced gene 1 protein; orphan G-prot;
PCGF1
polycomb group ring finger 1
PCGF1; polycomb group ring finger 1; NSPC1; RNF68; RNF3A-2; 2010002K04Rik; polycomb group RING finger protein 1; RING finger protein 68; nervous system Polycomb-1;
SLC14A1
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
SLC14A1; solute carrier family 14 (urea transporter), member 1 (Kidd blood group); JK; urea transporter 1; HsT1341; blood group Kidd urea transporter; HUT11; Kidd; kidd (JK) blood group urea transporter B1; RACH1; solute carrier family 14 (urea transporter) member 1 (Kidd blood group); urea transporter B1; Urea transporter erythrocyte; urea transporter JK glycoprotein; UT B1; UT1; UTE; SLC14A1 JK; OTTHUMP00000163453; urea transporter-B1; urea transporter, erythrocyte; UT-B1;
PDGFRL
platelet-derived growth factor receptor-like
PDGFRL; platelet-derived growth factor receptor-like; platelet-derived growth factor receptor-like protein; PRLTS; PDGFR-like protein; PDGF receptor beta-like tumor suppressor; platelet-derived growth factor-beta-like tumor suppressor; PDGRL;
PLA2G2C
phospholipase A2, group IIC
PLA2G2C; phospholipase A2, group IIC; phospholipase A2, group IIC (possible pseudogene); putative inactive group IIC secretory phospholipase A2; Phosphatidylcholine 2-acylhydrolase-like protein GIIC;
PLA2G3
phospholipase A2, group III
PLA2G3; phospholipase A2, group III; group 3 secretory phospholipase A2; GIII SPLA2; sPLA2-III; group III secreted phospholipase A2; group III secretory phospholipase A2; phosphatidylcholine 2-acylhydrolase 3; phosphatidylcholine 2-acylhydrola;
PLA2G4C
phospholipase A2, group IVC (cytosolic, calcium-independent)
PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent); cytosolic phospholipase A2 gamma; cPLA2 gamma; phospholipase A2 group IVC; CPLA2-gamma; FLJ42247; FLJ44164; DKFZp586C0423;
PLA2G4D
phospholipase A2, group IVD (cytosolic)
PLA2G4D; phospholipase A2, group IVD (cytosolic); cytosolic phospholipase A2 delta; cPLA2delta; cPLA2 delta; Phospholipase A2 group IVD; cPLA2-delta; phospholipase A2 delta, cytosolic;
PLA2G4E
phospholipase A2, group IVE
PLA2G4E; phospholipase A2, group IVE; cytosolic phospholipase A2 epsilon; FLJ45651; cPLA2-epsilon; MGC126633; MGC126661;
PLA2G4F
phospholipase A2, group IVF
PLA2G4F; phospholipase A2, group IVF; cytosolic phospholipase A2 zeta; PLA2G4F/Z; cPLA2-zeta; PLA2G4FZ; DKFZp666G192; DKFZp781B229;
INTS12
integrator complex subunit 12
INTS12; integrator complex subunit 12; PHD finger protein 22 , PHF22; hypothetical nuclear factor SBBI22; INT12; SBBI22; PHD finger protein 22; PHF22;
INTS9
integrator complex subunit 9
INTS9; integrator complex subunit 9; CPSF2L; FLJ10871; RC 74; CPSF2; CPSF; INT9; INTS 9; Protein related to CPSF subunits of 74 kDa; Related to CPSF subunits 74 kDa; OTTHUMP00000225629; OTTHUMP00000225630; OTTHUMP00000225631; OTTHUMP00000225632; RC74;
SFPI1
SFFV proviral integration 1
SFPI1; SFFV proviral integration 1; transcription factor PU.1; 31 kDa Transforming Protein; 31 kDa-transforming protein; Hematopoietic transcription factor PU.1; OF; PU.1; SPI 1 proto oncogene; SPI A; Spi1; SPI1_HUMAN; Spleen focus forming virus (SFFV) proviral integration oncogene spi1; Spleen Focus Forming Virus Proviral Integration Oncogene; SFFV proviral integration 1 protein; Dis1; Dis-1; Spi-1; Sfpi-1; Tcfpu1; Tfpu.1;
RGPD5
RANBP2-like and GRIP domain containing 5
RGPD5; RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain-containing protein 5/6; BS 63; DKFZp686I1842; RGP5; BS63; Ran binding protein 2 like 1; RANBP2 like and GRIP domain containing 5; RANBP2L1; RGPD8; Sperm membrane protein BS63; ranBP2L2; ranBP2-like 1; ranBP2-like 2; ranBP2-like 1/2; ran-binding protein 2-like 1; ran-binding protein 2-like 2; sperm membrane protein BS-63; ran-binding protein 2-like 1/2; RANBP2-like and GRIP domain-containing protein 5; RANBP2-like and GRIP domain-containing protein 6; BS-63; RGPD6;
SH3GL3
SH3-domain GRB2-like 3
SH3GL3; SH3-domain GRB2-like 3; endophilin-A3; CNSA3; EEN B2; HsT19371; SH3D2C; SH3P13; EEN 2B L3; EEN2BL3; EENB2; Endophilin 3; Endophilin A3; H.sapiens mRNA for protein containing SH3 domain, SH3GL3; SH3 domain containing GRB2 like protein 3; SH3 domain GRB2 like 3; SH3 domain protein 2C; endophilin-3; SH3 domain-containing GRB2-like protein 3; EEN-B2; EEN-2B-L3;
SH3GLB2
SH3-domain GRB2-like endophilin B2
SH3GLB2; SH3-domain GRB2-like endophilin B2; SH3 domain, GRB2 like, endophilin B2; endophilin-B2; KIAA1848; Endophilin B2; OTTHUMP00000022320; PP6569; PP9455; SH3 containing protein SH3GLB2; SH3 domain GRB2 like endophilin B2; SH3 domain-containing GRB2-like protein B2; SHLB2_HUMAN; SH3-containing protein SH3GLB2;
TIA1
TIA1 cytotoxic granule-associated RNA binding protein
TIA1; TIA1 cytotoxic granule-associated RNA binding protein; WDM; TIA-1; nucleolysin TIA-1 isoform p40; p40-TIA-1 (containing p15-TIA-1); T-cell-restricted intracellular antigen-1;
SYS1
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae)
SYS1; SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae); C20orf169, chromosome 20 open reading frame 169; protein SYS1 homolog; dJ453C12.4; 2610042O14Rik; AI266964; C20orf169; C87389; dJ453C12.4.1; SYS1 Golgi localized integral membrane protein homolog (S. cerevisiae);
TBRG1
transforming growth factor beta regulator 1
TBRG1; transforming growth factor beta regulator 1; FLJ14621; NIAM; nuclear interactor of ARF and MDM2; TB 5; TB-5;
TBC1D9
TBC1 domain family, member 9 (with GRAM domain)
TBC1D9; TBC1 domain family, member 9 (with GRAM domain); TBC1 domain family, member 9; TBC1 domain family member 9; KIAA0882; MDR1; TBC1 domain family member 9A;
WNT16
wingless-type MMTV integration site family, member 16
WNT16; wingless-type MMTV integration site family, member 16; protein Wnt-16; wingless-type MMTV integration site family member 16b;
USMG5
up-regulated during skeletal muscle growth 5 homolog (mouse)
USMG5; up-regulated during skeletal muscle growth 5 homolog (mouse); upregulated during skeletal muscle growth 5 , upregulated during skeletal muscle growth 5 homolog (mouse); up-regulated during skeletal muscle growth protein 5; bA792D24.4; DAPIT; MGC14697; DKFZp566D211; HCV F-transactivated protein 2; HCVFTP2; Up regulated during skeletal muscle growth 5 homolog (mouse); USMG5_HUMAN; upregulated during skeletal muscle growth 5 homolog;
XG
Xg blood group
XG; Xg blood group; PBDX, Xg blood group (pseudoautosomal boundary divided on the X chromosome); glycoprotein Xg; MGC118758; MGC118759; MGC118760; MGC118761; PBDX; XG glycoprotein; Xg blood group (pseudoautosomal boundary-divided on the X chromosome);
UCMA
upper zone of growth plate and cartilage matrix associated
UCMA; upper zone of growth plate and cartilage matrix associated; C10orf49, chromosome 10 open reading frame 49; unique cartilage matrix-associated protein; AW121955; C10orf49; Grp; 1110017I16Rik; Gla rich protein; Gla-rich protein; OTTMUSP00000011599; RP23-272I15.1; Ucma-C; UCMA_HUMAN; Unique cartilage matrix associated protein; Unique cartilage matrix-associated protein C-terminal fragment;
XK
X-linked Kx blood group (McLeod syndrome)
XK; X-linked Kx blood group (McLeod syndrome); Kell blood group precursor (McLeod phenotype) , XK, Kell blood group complex subunit (McLeod syndrome); membrane transport protein XK; Kx; Kx antigen; X1k; XKR1; Kell complex 37 kDa component; XK related protein 1; XRG1; XK-related protein 1; Kell blood group precursor (McLeod phenotype); XK, Kell blood group complex subunit (McLeod syndrome); MCLDS;
XKR4
XK, Kell blood group complex subunit-related family, member 4
XKR4; XK, Kell blood group complex subunit-related family, member 4; X Kell blood group precursor related family, member 4; XK-related protein 4; KIAA1889; X Kell blood group precursor-related family, member 4; XRG4;
XKR8
XK, Kell blood group complex subunit-related family, member 8
XKR8; XK, Kell blood group complex subunit-related family, member 8; X Kell blood group precursor related family, member 8; XK-related protein 8; FLJ10307; RP11-460I13.3; X Kell blood group precursor-related family, member 8; XKR8_HUMAN; XRG8;
XKRY2
XK, Kell blood group complex subunit-related, Y-linked 2
XKRY2; XK, Kell blood group complex subunit-related, Y-linked 2; X Kell blood group precursor related, Y linked 2 , X Kell blood group precursor related, Y linked pseudogene 7 , XKRYP7; testis-specific XK-related protein, Y-linked 2; Y-linked 2; Testis-specific XK-related protein; X Kell blood group precursor related, Y linked 2; X Kell blood group precursor related, Y linked pseudogene 7; XK, Kell blood group complex subunit related, Y linked 2; XKRY2_HUMAN; XKRYP7; X Kell blood group precursor-related, Y-linked 2; X Kell blood group precursor-related, Y-linked pseudogene 7;
WNT10A
wingless-type MMTV integration site family, member 10A
WNT10A; wingless-type MMTV integration site family, member 10A;
WNT5B
wingless-type MMTV integration site family, member 5B
WNT5B; wingless-type MMTV integration site family, member 5B; protein Wnt-5b; WNT-5B protein; MGC2648;
WNT6
wingless-type MMTV integration site family, member 6
WNT6; wingless-type MMTV integration site family, member 6; protein Wnt-6;
WNT7A
wingless-type MMTV integration site family, member 7A
WNT7A; wingless-type MMTV integration site family, member 7A; protein Wnt-7a; proto oncogene Wnt7a protein; proto-oncogene Wnt7a protein; px; tw; Wnt-7a; AI849442;
WNT7B
wingless-type MMTV integration site family, member 7B
WNT7B; wingless-type MMTV integration site family, member 7B; protein Wnt-7b; Wingless related MMTV integration site 7B; Wingless type MMTV integration site family member 7B;
WNT8A
wingless-type MMTV integration site family, member 8A
WNT8A; wingless-type MMTV integration site family, member 8A; protein Wnt-8a; WNT8D; protein Wnt-8d;
WNT8B
wingless-type MMTV integration site family, member 8B
WNT8B; wingless-type MMTV integration site family, member 8B; protein Wnt-8b;
WNT9B
wingless-type MMTV integration site family, member 9B
WNT9B; wingless-type MMTV integration site family, member 9B; WNT15; WNT14B; protein Wnt-9b; protein Wnt-14b; wingless-type MMTV integration site family, member 15;
GCOM1
GRINL1A complex locus 1
GCOM1; GRINL1A complex locus 1; GRINL1A combined protein; FLJ30973; GRINL1A; MYZAP POLR2M; MYZAP POLR2M readthrough; Gcom2; Glutamate receptor ionotropic N methyl D aspartate like 1A combined; GRINL1A combined protein Gcom12; GRINL1A upstream protein; Gup1; Gup2; MGC126694; MGC138353; NMDAR1 subunit interacting protein; OTTHUMP00000163287; MYZAP-POLR2M protein; MYZAP-POLR2M readthrough; GRINL1A complex locus protein 1; NMDAR1 subunit-interacting protein; glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A combined protein; gcom; MYZAP-POLR2M;
GRB14
growth factor receptor-bound protein 14
GRB14; growth factor receptor-bound protein 14; GRB14 adapter protein; Growth factor receptorbound protein 14;
GP2
glycoprotein 2 (zymogen granule membrane)
GP2; glycoprotein 2 (zymogen granule membrane); pancreatic secretory granule membrane major glycoprotein GP2; pancreatic zymogen granule membrane protein GP-2; pancreatic zymogen granule membrane associated protein GP2; ZAP75; DKFZp779K0533;
GHITM
growth hormone inducible transmembrane protein
GHITM; growth hormone inducible transmembrane protein; growth hormone-inducible transmembrane protein; DERP2; HSPC282; My021; PTD010; TMBIM5; transmembrane BAX inhibitor motif containing 5; dermal papilla-derived protein 2; mitochondrial morphology and cr;
TOX3
TOX high mobility group box family member 3
TOX3; TOX high mobility group box family member 3; TNRC9, trinucleotide repeat containing 9; CAGF9; trinucleotide repeat containing 9; trinucleotide repeat-containing gene 9 protein; CAG trinucleotide repeat-containing gene F9 protein; TNRC9;
TIAL1
TIA1 cytotoxic granule-associated RNA binding protein-like 1
TIAL1; TIA1 cytotoxic granule-associated RNA binding protein-like 1; TIA1 cytotoxic granule associated RNA binding protein like 1; nucleolysin TIAR; TIAR; T-cluster binding protein; TIA-1-related nucleolysin; aging-associated gene 7 protein; TCBP; MGC3340;
WNT2
wingless-type MMTV integration site family member 2
WNT2; wingless-type MMTV integration site family member 2; INT1L1; protein Wnt-2; IRP; secreted growth factor; int-1-like protein 1; Int-1-related protein;
WNT3
wingless-related MMTV integration site 3
WNT3; wingless-related MMTV integration site 3; Int-4; Wnt-3; proto-oncogene Wnt-3; proto-oncogene Int-4; proto-oncogene protein Wnt-3;
GDF1
growth differentiation factor 1
GDF1; growth differentiation factor 1; embryonic growth/differentiation factor 1; GDF-1; DORV; DTGA3;
PEAR1
platelet endothelial aggregation receptor 1
PEAR1; platelet endothelial aggregation receptor 1; MEGF12, multiple EGF like domains 12; FLJ00193; JEDI; hPEAR1; multiple EGF-like-domains 12; multiple EGF-like domains protein 12; multiple epidermal growth factor-like domains protein 12; MEGF12;
Gzmg
granzyme G
Gzmg; granzyme G; Ctla7; Ctla-7; MCSP-1; AKA granzyme G; CTL serine protease 1; CTL serine protease 3;
HMGN2
high mobility group nucleosomal binding domain 2
HMGN2;high mobility group nucleosomal binding domain 2;4986;ENSG00000198830;HMG17;1p36.1;MGC5629, MGC88718;non-histone chromosomal protein HMG-17;non-histone chromosomal protein HMG-17;high mobility group protein N2;nonhistone chromosomal protein HMG-17;high-mobility group nucleosomal binding domain 2;high-mobility group (nonhistone chromosomal) protein 17;high mobility group nucleosome-binding domain-containing protein 2;
FLG2
filaggrin family member 2
FLG2;filaggrin family member 2;33276;ENSG00000143520;IFPS;1q21.3;filaggrin-2;filaggrin-2;FLG-2;filaggrin 2;ifapsoriasin;intermediate filament-associated and psoriasis susceptibility protein;intermediate filament-associated and psoriasis-susceptibility protein;
GAB4
GRB2-associated binding protein family, member 4
GAB4;GRB2-associated binding protein family, member 4;18325;22q11.1;GRB2-associated-binding protein 4;GRB2-associated-binding protein 4;GRB2-associated binder 4;GRB2-associated binder 2-like protein;growth factor receptor bound protein 2-associated protein 4;
GAPT
GRB2-binding adaptor protein, transmembrane
GAPT;GRB2-binding adaptor protein, transmembrane;26588;ENSG00000175857;C5orf29;5q11.2;FLJ33641, MGC70478;protein GAPT;protein GAPT;GRB2-binding transmembrane adaptor;growth factor receptor-bound protein 2-binding adapter protein, transmembrane;
GCC2
GRIP and coiled-coil domain containing 2
GCC2;GRIP and coiled-coil domain containing 2;23218;ENSG00000135968;REN53;GCC185;RANBP2L4;2q12.3;KIAA0336;GRIP and coiled-coil domain-containing protein 2;GRIP and coiled-coil domain-containing protein 2;GCC protein, 185-kD;CTCL tumor antigen se1-1;CLL-associated antigen KW-11;Ran-binding protein 2-like 4;Golgi coiled-coil protein GCC185;185 kDa Golgi coiled-coil protein;renal carcinoma antigen NY-REN-53;
GIGYF1
GRB10 interacting GYF protein 1
GIGYF1;GRB10 interacting GYF protein 1;9126;ENSG00000146830;GYF1;PERQ1;7q22;PERQ amino acid-rich with GYF domain-containing protein 1;PERQ amino acid-rich with GYF domain-containing protein 1;GYF domain containing 1;GRB10-interacting GYF protein 1;PERQ amino acid rich, with GYF domain 1;postmeiotic segregation increased 2-like 12;
GRAMD1C
GRAM domain containing 1C
GRAMD1C;GRAM domain containing 1C;25252;ENSG00000178075;3q13.31;FLJ35862, FLJ40464, DKFZp434C0328, DKFZp686K06117;GRAM domain-containing protein 1C;GRAM domain-containing protein 1C;
GRAMD4
GRAM domain containing 4
GRAMD4;GRAM domain containing 4;29113;ENSG00000075240;DIP;dA59H18.1;dJ439F8.1;22q13.31;KIAA0767, MGC90497, MGC149847;GRAM domain-containing protein 4;GRAM domain-containing protein 4;death-inducing protein;death-inducing-protein;
GRID2IP
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein
GRID2IP;glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein;18464;ENSG00000215045;DELPHILIN;7p22.1;delphilin;delphilin;glutamate receptor, ionotropic, delta 2-interacting protein 1;glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1;
INTS1
integrator complex subunit 1
INTS1;integrator complex subunit 1;24555;ENSG00000164880;INT1;NET28;7p22.3;FLJ46624, KIAA1440, DKFZp586J0619;integrator complex subunit 1;integrator complex subunit 1;
NYNRIN
NYN domain and retroviral integrase containing
NYNRIN;NYN domain and retroviral integrase containing;20165;ENSG00000205978;CGIN1;KIAA1305;14q12;FLJ11811, KIAA1305;protein NYNRIN;protein NYNRIN;Cousin of GIN1;protein cousin of GIN1;NYN domain and retroviral integrase catalytic domain-containing protein;
EPG5
ectopic P-granules autophagy protein 5 homolog (C. elegans)
EPG5;ectopic P-granules autophagy protein 5 homolog (C. elegans);29331;ENSG00000152223;HEEW1;hEPG5;KIAA1632;18q12.3;KIAA1632, DKFZp667P2311;ectopic P granules protein 5 homolog;ectopic P granules protein 5 homolog;
OGFRL1
opioid growth factor receptor-like 1
OGFRL1;opioid growth factor receptor-like 1;21378;ENSG00000119900;dJ331H24.1;6q13;FLJ21079, MGC102783;opioid growth factor receptor-like protein 1;opioid growth factor receptor-like protein 1;
RGPD1
RANBP2-like and GRIP domain containing 1
RGPD1;RANBP2-like and GRIP domain containing 1;32414;ENSG00000187627;RGP1;RGPD2;RanBP2L2;2p11.2;FLJ58076;RANBP2-like and GRIP domain-containing protein 1;RANBP2-like and GRIP domain-containing protein 1;ranBP2L6;ranBP2-like 6;ranBP2-like 2/6;ran-binding protein 2-like 6;ran-binding protein 2-like 2/6;RANBP2-like and GRIP domain-containing protein 1/2;
TGFBRAP1
transforming growth factor, beta receptor associated protein 1
TGFBRAP1;transforming growth factor, beta receptor associated protein 1;16836;ENSG00000135966;TRAP1;TRAP-1;2q12.1;transforming growth factor-beta receptor-associated protein 1;transforming growth factor-beta receptor-associated protein 1;TGF-beta receptor-associated protein 1;TGF beta receptor associated protein -1;
TBC1D9B
TBC1 domain family, member 9B (with GRAM domain)
TBC1D9B;TBC1 domain family, member 9B (with GRAM domain);29097;ENSG00000197226;5q35.3;FLJ41880, KIAA0676, MGC157757;TBC1 domain family member 9B;TBC1 domain family member 9B;
XKR3
XK, Kell blood group complex subunit-related family, member 3
XKR3;XK, Kell blood group complex subunit-related family, member 3;28778;ENSG00000172967;XRG3;XTES;22q11.1;MGC57211;XK-related protein 3;XK-related protein 3;expressed in testis;x Kell blood group-related 3;X Kell blood group precursor-related family, member 3;
XKR6
XK, Kell blood group complex subunit-related family, member 6
XKR6;XK, Kell blood group complex subunit-related family, member 6;27806;ENSG00000171044;XRG6;C8orf5;C8orf7;C8orf21;8p23.1;FLJ31557;XK-related protein 6;XK-related protein 6;Transmembrane protein C8orf5;X Kell blood group precursor-related family, member 6;
XKR7
XK, Kell blood group complex subunit-related family, member 7
XKR7;XK, Kell blood group complex subunit-related family, member 7;23062;ENSG00000101321;C20orf159;dJ310O13.4;20q11.21;XK-related protein 7;XK-related protein 7;X Kell blood group precursor-related family, member 7;
XKR9
XK, Kell blood group complex subunit-related family, member 9
XKR9;XK, Kell blood group complex subunit-related family, member 9;20937;ENSG00000221947;XRG9;8q13.3;XK-related protein 9;XK-related protein 9;X Kell blood group precursor-related family, member 9;
WNT9A
wingless-type MMTV integration site family, member 9A
WNT9A;wingless-type MMTV integration site family, member 9A;12778;ENSG00000143816;WNT14;1q42;MGC138165, MGC141991;protein Wnt-9a;protein Wnt-9a;wingless-type MMTV integration site family, member 14;
WNT11
wingless-type MMTV integration site family, member 11
WNT11;wingless-type MMTV integration site family, member 11;12776;ENSG00000085741;HWNT11;11q13.5;MGC141946, MGC141948;protein Wnt-11;protein Wnt-11;
Gramd1b
GRAM domain containing 1B
GRAMD1B;GRAM domain containing 1B;ENSMUSG00000040111;AI593249;mKIAA1201;3222402H23;A930008A22Rik;9;9 B;KIAA1201;GRAM domain-containing protein 1B;GRAM domain-containing protein 1B;
VGF
VGF nerve growth factor inducible
VGF;VGF nerve growth factor inducible;12684;ENSG00000128564;7q22.1;neurosecretory protein VGF;neurosecretory protein VGF;neuro-endocrine specific protein VGF;
BANF2
barrier to autointegration factor 2
BANF2;barrier to autointegration factor 2;16172;ENSG00000125888;BAF2;BAFL;BAF-L;C20orf179;20p12.1;MGC62093, MGC72082;barrier-to-autointegration factor-like protein;barrier-to-autointegration factor-like protein;barrier-to-autointegration factor 2;
GINM1
glycoprotein integral membrane 1
GINM1;glycoprotein integral membrane 1;21074;ENSG00000055211;C6orf72;dJ12G14.2;6q25.1;uncharacterized protein C6orf72;uncharacterized protein C6orf72;
EDEM3
ER degradation enhancer, mannosidase alpha-like 3
EDEM3;ER degradation enhancer, mannosidase alpha-like 3;16787;ENSG00000116406;C1orf22;1q25;ER degradation-enhancing alpha-mannosidase-like 3;ER degradation-enhancing alpha-mannosidase-like 3;ER degradation-enhancing -mannosidase-like protein 3;
Abo2
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
Abo2;
ASCC3
ASCC3 activating signal cointegrator 1 complex subunit 3 [ Homo sapiens ]
Ascc3; activating signal cointegrator 1 complex subunit 3; helicase, ATP binding 1;
CSF2RB2
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage)
Bil3; Il3r; AIC2A; Il3rb; Il3rb2; BetaIl3; Csfgmrb;
RGD1565734_predicted
excision repair cross-complementing rodent repair deficiency complementation group 6 - like
RGD1565734;
Gcap14
granule cell antiserum positive 14
Fam190b; AI035535; AW108503; 1700012P13Rik; 2900054P12Rik;
Magmas
mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction
RGP1
RGP1 retrograde golgi transport homolog (S. cerevisiae)
AI527196; mKIAA0258; F730001J03; 1110029E03Rik; RP23-191F22.3;
Adam6
a disintegrin and metallopeptidase domain 6
Adam6; TMDCIV; a disintegrin and metallopeptidase domain 6; tMDC IV; a disintegrin and metalloproteinase domain 6;
Fgfbp3
Fibroblast Growth Factor Binding Protein 3
Fibroblast Growth Factor Binding Protein 3; FGFBP3;
IGFII
insulin-like growth factor 2 (somatomedin A)
IGF-II; PP9974; C11orf43; IGF2; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734;
PDGFRα
platelet-derived growth factor receptor, alpha polypeptide
CD140A; PDGFR2; PDGFR-2; RHEPDGFRA;
TGFβR2
transforming growth factor, beta receptor II (70/80kDa)
AAT3; FAA3; MFS2; RIIC; LDS1B; LDS2B; TAAD2; TGFR-2; TGFbeta-RII;
FCGR2C
FCGR2C Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) [ Homo sapiens ]
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene); 15626; low affinity immunoglobulin gamma Fc region receptor II-c; fc-gamma-RIIc; IgG Fc receptor II-c; Fc gamma receptor IIC; immunoglobulin G Fc receptor II-c; CD32; FCG2; CD32C; CDW32; IGFR2; FCRIIC;
HCG9
HCG9 HLA complex group 9 (non-protein coding) [ Homo sapiens (human) ]
HLA complex group 9 (non-protein coding); PERB11; HCGIX; HCG IX; HCGIX4; HLA complex group 9; HcgIX protein; HCGIX-4;
phosphatidylserine
Escherichia coli serogroup O45
Bacteria; Eubacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia; E. coli; Escherichia coli; E. coli O45; Escherichia coli serogroup O45;
Integrated Drug Development & Manufacturing Bioprocess Development
With proven experience and expertise in mammalian cell culture, Creative BioMart is prestigious one-stop solution provider for the full range of biopharmaceutical development and manufacturing services. Cell Line Development Stable cell line development services at Creative BioMart offer rapid turna...
Epidermal Growth Factor Receptor and Its Applications
The discovery of growth factors won the Nobel Prize in Medicine in 1986, implying their importance. Epidermal growth factor receptor, EGFR, one of such factors, exists on cell surface and is activated by binding of its specific ligands. EGFR is a member of the receptor tyrosine kinase family who...
Simple Analysis of the Growing Market of Growth Hormone
With the overall improvement of biomedical technology and basic requirements, growth hormone (GH) market is growing rapidly in recent years. Growth hormone is the power source of growing Secreted by anterior pituitary...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
Biosimilars Global Congress 2014 Europe within One Week
Biosimilars Global Congress 2014 Europe is going to be held in Sep 17th to Sep 19th 2014 from 8:30 am to 6:00 pm in Financial District, Boston. This Congress is to give a platform for interactive discussion and communication about practical strategies on challenges, innova...
The 4th Annual Next Generation Sequencing Congress in 2012
Where senior practitioners both of academia and pharma would gather together Why Over 350 experts from both academia and pharma senior practitioners engaged in kinds of next generation sequencing including personalized healthcare/clinical/diagnostic development, genomics, epigenetics, DNA Met...
The 2nd Annual Cell Culture World Congress USA in Boston
Introduction The 2nd annual Cell Culture World Congress USA is North America's leading conference focused on the optimization and development of cell culture bioproduction. This is a chance for biopharma, biotechs, biomanufacturing and process experts come to debate advances in cell culture optim...
The 2013 Biggest and Most Comprehensive Event for the Vaccine Industry—the 13th Annual World Vaccine Congress & Expo
When From April 16 to April 18, 2013 Where Gaylord National Hotel Convention Center, Maryland MD, US Introduction The 2...
2013, the 2nd Biotechnology World Congress
Agenda Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular , endocrine, immune); vaccines; antibodies ; protein engineering. Plant and Environm...
The 9th European Antibody Congress
When Nov. 11 to Nov. 13, 2013 Where Starling Geneva Hotel Conference Center, Geneva, Switzerland Introduction Organized by Terrapinn, the tree days event brings the monoclonal antibody (mAb) and next generation technology industry together. The conference will focus on mAb researc...
The 2013 Asia Antibody Congress
When June 10-13, 2013 Where 392 Havelock Road, Grand Copthorne Waterfront Hotel, Singapore Introduction The 2013 Asia Antibody Congres...
The 2013 World Biotechnology Congress
When June 3-6, 2013 Where 900 Boylston Street, Hynes Convention Center, Boston, MA, United States Introduction The World Biotechnology Co...
The 2nd Anticancer Agents Congress: Targeting Cancer Stem Cell
When November 21 to 24th 2013 Where Belek, Antalya, Turkey (the congress hotel will be announced soon) Introduction Sponsored by EACR, the meeting aims to bring all kinds of anti-cancer agents researchers together and discuss recent achievements in the field of basic research on ...
HOLIDAY GREETINGS 2020
When the world celebrates Christmas and New Year, we feel like taking this opportunity to send you our best wishes. We would also like to continue our commitment to excellent products and services as always. Thank you for choosing Creative BioMart. May your life be filled with warmth and good cheer ...
2021 Thanksgiving Greetings
Thanksgiving is a time of reflection for all our blessings. Your kindness and support count for so much. We appreciate having you as a customer and a friend. May your Thanksgiving be full of peace, love and joy. Happy Thanksgiving! What we offer? Get 5 10% off for all products and se...
HOLIDAY GREETINGS 2021
Warmest wishes for Christmas because you keep our business warm throughout the year. Working with you has been a pleasure, thank you for being so supportive. We wish you a joyful Christmas and a prosperous new year! What we offer? 10% off on all products and services on Creative BioMa...
HOLIDAY GREETINGS 2022
The occasion of Thanksgiving gives us the opportunity to express our gratitude for having such an inspiring client like you. May this Thanksgiving be full of happiness and joys for you and your loved ones. What we offer? 10% off on products and 5% off on services on Creative BioMart. ...
Protocol of Immobilized Metal Affinity Chromatography
In addition to the enrichment of phosphorylated proteins, phosphorylated peptides can also be enriched. There are many ways to enrich phosphorylated peptides. Immobilized metal affinity chromatography (IMAC) was first proposed by Porath in 1975. After decades of development, it has become the most p...
Guide for Enrichment of Phosphorylated Peptides by Strong Cation Exchange Chromatography
The most commonly used method for the enrichment of phosphorylated peptides is the solid-phase metal ion affinity chromatography (IMAC) described earlier. Although IMAC is relatively simple and fast in application, strong cation exchange chromatography has shown more superior effectiveness in large-...
Guide for Mass Spectrometry Identification of Samples Separated by Liquid Chromatography
As one of the most powerful separation and analysis technologies in the field of chemistry, liquid chromatography (LC) has developed rapidly since the 1970s. Both in terms of fundamental chromatography theory and instrument performance, it has been greatly improved and improved. LC exhibits high sep...
X-ray Crystallography
1. Introduction X-ray crystallography is a technique used for determining the high-resolution, three-dimensional crystal structures of atom and molecules and has been fundamental in the development of many scientific fields. In its first decades of application, it is mainly used for determining the ...
What is GRN Protein
See All GRN Protein Products Each biological molecule plays a vital role in maintaining the delicate balance of life. Among them, the GRN (progranulin) protein plays a key role in coordinating various cellular processes. What is GRN Protein? GRN protein, encoded by the GRN gene located on chromoso...
